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The need for a direct visual response system for the detection of organophosphorus 
compounds stems from the continued threat and use of these toxic agents in military and 
terrorist conflicts. The development of an enzyme-inhibitor triggered release system allows 
for direct visual detection with high specificity. Mesoporous silica nanoparticles (MSNs) 
have physical features that make them attractive as scaffolds for the construction of these 
systems, such as pore diameters (20-500 Å) that can be synthetically controlled, large 
surface areas (300-1500 m2g-1), large pore volumes, chemical inertness, stability at 
elevated temperatures, and surfaces that can be easily functionalized. In our studies, the 
dye Congo Red was loaded into the pores of MSNs, which were then capped by tethering 
an enzyme (organophosphorus hydrolase (OPH) or acetylcholinesterase (AChE)) to the 
external surfaces of MSNs through a competitive inhibitor (diethyl 4-aminobenzyl 
phosphonate (DEABP) or tacrine, respectively). OPH has been extensively studied for its 
ability to hydrolyze a wide range of organophosphorus compounds, rendering them non-
toxic. AChE has been commonly used for organophosphate detection resulting from its 
sensitivity to phosphorylation. Upon addition of organophosphorus compounds to 
suspensions of the modified MSNs, the enzymes detached from the MSN surface, releasing 
the dye and providing a visual confirmation of organophosphate presence. Enzyme kinetics 
were studied using 31P NMR or UV-Visible spectroscopy; Congo Red release was also 
monitored by UV-Visible spectroscopy. The system was sensitive and specific for 
organophosphorus compounds both in phosphate-buffered saline and in human serum. The 
rate of dye release directly correlated with the rate of organophosphorus conversion for 
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CHAPTER 1: BACKGROUND ON TRIGGERED-RESPONSE SYSTEMS AND 
MESOPOROUS SILICA NANOPARTICLES 
 
1.1. Triggered-Response Systems  
 The unique ability of an organism or biological system to respond to an external 
stimulus has driven research to understand these complex systems.1 Exploration of stimuli 
responsive processes has in turn driven the development of new materials and systems to 
mimic these complex response systems. The specific stimuli that results in a “triggered-
response” of the system can be built into the material through synthetic or post-synthetic 
functionalization.2-12 This requires the use of a material that can be readily tailored, to meet 
the specific requirements (“trigger-specificity”) needed for the system to respond. This has 
made the use of polymer-based materials particularly attractive, because they can be 
produced in large amounts and chemical functionality can be incorporated during the 
synthesis or post-synthetically with a variety of molecular architectures.1  
The use of polymer-based materials as trigger-responsive systems has contributed 
to the tremendous growth within this area over the past two decades. The breadth of 
combinations of polymeric architectures and functionality has allowed for manipulation of 
the material to effectively respond to a variety of small changes within their external 
environment. One of the earliest examples of thermosensitive polymers, poly(N-
isopropylacrylamide), which formed transitions from linear to globular across its lower 
critical solution temperature (LCST = 32°C) in aqueous solution (Figure 1.1).1 Similarly, 
the use of poly(acrylamide) crosslinking leads to the formation of polymeric gels that can  
  
 2 
retain stability across the LCST during solvation/desolvation, resulting from changes in 
temperature, or pH (Figure 1.1).1 Advancements in polymer-based materials have led to 
materials that response to a variety of additional environmental and chemical changes such 
as pH,13-17 temperature,18-22 magnetic fields,23-27 light28-29 or biological-based processes 
such as enzyme signaling.30-34 The design of the material and response system controls 
directly the ability of the system to react when exposed to one of these external stimuli.1, 
25, 35-36  
 
 
Figure 1.1: Coil-to-globular transition of poly(n-isoproplyacrylamide) dependent on temperature 
(top) and gel solvation/desolvation of poly(acrylamide) dependent on temperature, or pH.1 
 
 
1.2. Design of a Triggered-Response System 
 Development of a triggered-response system based on a polymeric material 
requires several key aspects to be adequately addressed. These include: the selection of the  
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base scaffold (polymeric material), the trigger (change in external environment) and the 
response (chemical and/or physical). While each aspect can be individually considered as 
the primary controlling design factor, the cooperation of all three components is required 
in a complete triggered-response system.37 In triggered-release systems for detection 
applications, an analyte molecule is the trigger releasing mechanism, activating a 
secondary signal such as a colorimetric38-39 or fluorimetric39-40 response to indicate the presence 
of the analyte such as the utilization of photo-induced electron transfer (PET) processes for 
fluorescent chemosensors to indicate the presence of organophosphorus substrates. These 
rely on an alcohol in close proximity to a tertiary amine with an appended fluorophore, 
quenched by the PET. The introduction of an organophosphorus compound converts the 
hydroxyl group to a phosphate ester followed by an ammonium salt, increasing the 
fluorescence (Figure 1.2).41  
 
 
Figure 1.2: Detection of organophosphorus compound using a PET sensor.41 
 
Increasing the “response” of the signal requires the immobilization of the  
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triggered-response system. Localization of the response increases the overall signal and 
stabilizes system. The utilization of MSNs, specifically, allow for the localization of not 
only the triggered-response system but offers stability, and rigidity to extend the life of the 
system through control of the physical characteristics and post-synthetic 
functionalization.42  
1.3. Mesoporous Silica Nanoparticles (MSNs) 
 The use of a porous material offers several advantages over other polymeric 
architectures in triggered-release systems, primarily a large internal pore volume that can 
be used to load and retain large amounts of molecular cargo. Transporting the cargo within 
the scaffold can offer protection from the external environment until the desired location 
or stimulus is encountered. Controlling the loading and release of the cargo from the 
interior volume through the porous structure can be directly manipulated by the selection 
of pore diameter of the material. Silica-based materials are categorized based on their pore 
size. Microporous, mesoporous, and macroporous materials have pore diameters of less 
than 2 nm, 2-50 nm, and greater than 50 nm, respectively. Depending on the type of 
molecules that need to be loaded, carried and delivered, selection of the proper pore 
diameter and corresponding material can be determined.  
Mesoporous silica nanoparticles (MSNs) offer several advantages over previous 
mesoporous silica microspheres. They have a tunable particle size (50 – 300 nm) that has 
shown to be endocytosed by living animals and plant cells without any significant 
cytotoxicity. The spherical structure has shown to be rigid and stable to changes in heat,  
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pH and mechanical stress compared to other polymeric forms. In combination with these 
attributes, MSNs have pore diameters corresponding to the sizes of many biomolecules.37 
This was seen with the MSN-based system that facilitated the intercellular delivery of 
cyclic adenosine monophosphate (cAMP), loaded in the interior pore volume. 
Manipulation of the MSN surface resulted in the immobilization of a gluconic acid-
derivatized insulin that capped the material and was released in the presence of excess 
blood glucose (Figure 1.3).43 This has propelled the use of MSNs in a variety of 




Figure 1.3: Insulin-capped MSN. The removal of cap (a) is triggered by blood glucose (b) to release 
cAMP (c).43 
 
1.3.1. Synthesis of MSNs 
 The development of MSNs has progressed over the last two decades from their  
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application in several areas such as adsorption, chromatography, sensors, and drug 
delivery.45, 52 This stemmed from their original development as a new class of molecular 
sieves by the Mobil oil company. Typical microporous molecular sieves (zeolites), used 
for separations, were limited by their small pore diameters and the molecular range in 
which they would be useful for separations. The development of MCM-41 in 1992, the 
first mesoporous material, began a surge of new materials that retained the large surface 
areas of zeolites but had pore diameters greater than 2 nm. The most prominent 
representatives of this emerging material were the class of MCM-type materials. The use 
of ionic structure directing surfactants during the condensation of a silica precursor under 
basic conditions allowed for the development of several different pore structures (Figure 
1.4). This included the 2-dimensional, hexagonally arranged pores of MCM-41, MCM-48 
with a 3-dimensional, cubic arrangement and MCM-50 that had a laminar structure.52-54 
Alternatively, other synthetic methods were employed using variations in structure 
directing agents, and under acidic conditions those led to the development of SBA-type 




Figure 1.4: Scheme of the formation mechanism of MCM-41.TEOS: tetraethoxysilane.45 
  
Since this initial development, a broad range of synthetic procedures have been 
developed. Manipulation of reaction conditions (pH), the silica monomers, and structure-
directing surfactants chosen can all be used to control the synthesis of the desired material. 
These factors influence the type of interaction (electrostatic or hydrogen bonding) between 
the surfactant (S) and silica (I) (Figure 1.5). Electrostatic interactions can be manipulated 
by the pH of the reaction mixture and the type of surfactant. Under basic conditions, a 
cationic surfactant has a direct interaction with the silica giving a S+ - S- interaction. 
Alternatively, acidic conditions below the isoelectric point of the Si-OH (less than pH = 2) 
require the use of a counter-ion (X-) to mediate the S+ - I+ interaction. The use of an anionic 
surfactant has similar interactions depending on the pH of the reaction conditions. Under 
acidic conditions the interaction is S- - I+, while basic conditions require the addition of a  
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mediator (M+) for the S- - I- electrostatic interaction. When uncharged silica is used, a non-
ionic surfactant (I0) can form hydrogen bonds to have a S0 – I0 interaction. Hydrogen 
bonding can also occur in acidic conditions with the interaction of a charged silica surface 
and ion to form an ion pair (IX)0 to have a S0 – (IX)0 interaction. With numerous 
combinations of surfactant, silica and pH, further manipulation of the concentrations, 
temperature and reaction time allows additional control over particle diameter, morphology 
and pore structure of the MSN.52, 55-56 
 
 
Figure 1.5: Interactions between the inorganic species and the head group of the surfactant with 
consideration of the possible synthetic pathway in acidic, basic or neutral medial. a) S+I-, b) S+X-I+, c) 






1.3.2. Physical Characteristics of MSNs 
The primary physical characteristics that govern the ability of the scaffold to be 
an effective release system are pore diameter, pore structure, surface area, pore volume 
particle diameter, and particle morphology. Depending on the molecular cargo to be 
transported and delivered, adjustments to these characteristics can greatly affect loading 
and/or release. Previous research into the influence of each of these characteristics has 
given insight on how each one specifically controls the overall function of the system.45  
In general, pore diameter can drastically change the ability of a material to not 
only load a desired cargo but affect the release rate. Dependent on the size of the cargo, 
changing the diameter of the pore can increase or decrease the total amount loaded. 
Examples of this include the loading SBA-15 with a large cargo, such as a bovine serum 
albumin (BSA), in which increasing the pore diameter from 8.2 to 11.4 nm can almost 
double the loading from 0.15 grams BSA per gram of SBA-15 to 0.27 g/g. amount. This 
can be attributed to the steric constraints of pore diameter, and ability for the BSA to adjust 
its confirmation to pack tightly once in the interior.57 In another example, release studies 
using ibuprofen have shown pore diameter to drastically control delivery. Increasing the 
pore diameter by only 11 Å can increase the release rate fivefold.58 When factoring in the 
desired cargo that will be transported and its relative size, the selection of the proper pore 
diameter can be made. 
 Similarly, the availability of several different pore structures based on pore 
connectivity and geometry have shown to contribute to the loading and release of cargo. A 
SBA-1 mesoporous material with 3D cubic interconnected resulted in faster release of  
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ibuprofen compared to SBA-3 mesoporous material with a hexagonal geometry with a 
similar surface area, and pore diameter but unconnected pores. This was attributed to the 
interconnections between pores offering easier diffusion throughout the material, resulting 
in faster mass transport and release.45, 59-61 
 A major benefit of using mesoporous materials are their high surface areas and 
large pore volumes. While a small amount of surface area is derived from the exterior 
surface of the particle, the vast majority (at least 95% depending on the particle diameter) 
is from the interior surface of the material. This influences the quantity of cargo that can 
be loaded, controlled by the interaction of the cargo with the interior pore wall. Cargo that 
interacts with the interior pore surface has a direct correlation of surface area to the loading 
capacity of the material. Comparisons of unmodified materials with different surface areas, 
MCM-41 (1157 m2 g-1) versus SBA-15 (719 m2 g-1), have shown almost a twofold increase 
in loaded alendronate due to the direct interaction with the surface hydroxyl groups with 
hydrophilic molecules.60, 62 For hydrophobic molecular cargo, interior modification of the 
surface hydroxyl groups such as with 3-aminoproplytriethoxysilane, has shown to increase 
the loading of camptothecin.63 Whether the interaction with the pore wall occurs or not, 
filling of the remaining interior can be greatly influenced by the pore volume. Materials 
that have larger pore volumes, SBA-15 (1.1 cm3 g-1) versus mesocellular silica foams (1.9 
cm3 g-1) have shown to load almost double the amount of cargo. This can be attributed to 
the packing of the cargo within the pore, limited by only the dimensions of the cargo.45, 57, 
64 
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1.3.3. Functionalization of MSNs 
 The most beneficial aspect of using MSNs is their ability to easily modified with 
specific organic functional groups. Incorporation of a broad range of possible 
functionalities allows for the tailoring of the material as a specific triggered-release system. 
The three main ways of incorporating these new functionalities are through post-synthetic 
functionalization (grafting), co-condensation, and by using bridged alkoxysilane 
precursors ((RˈO)3Si-R-Si(ORˈ)3) (Figure 1.6). Each of these techniques differs in their 
approach to which the organic functionality can be added. Periodic mesoporous 
organosilicas (PMOs), created from bridged silanes, were designed to incorporate the 
functionality directly into the 3D network of the silica structure. This can be accomplished 
through the use of a bridge organosilica precursor, allowing for functionalization within 
the pore walls of the material.52, 65-66 Co-condensation relies on the addition of 
trialkoxyorganosilanes ((RˈO)3SiR) in a one-pot synthesis, containing the surfactant and 





Figure 1.6: Silica-based mesoporous organic-inorganic hybrid materials.52 
 
 
While each of these approaches result in the direct addition of organic moieties, 
both have several disadvantages for the use as a triggered release system. In general, PMOs 
often result in a disordered pore structure with a wide range of pore diameters, limiting the 
control of pore size. Similar effects have been seen with the co-condensation method, in 
which reductions in pore diameter, pore volume, and surface area can vary depending on 
the concentration of the trialkoxyorganosilane added. Uneven distribution, difficult access 
to the organic functionality, and the lack of compatible organic moieties to incorporate 
using these methods have all limited their use.52  
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1.3.3.1. Post-Synthetic Functionalization: Grafting 
 Grafting has become the primary method for adding organic functionality to 
MSNs when developing a triggered-release system. The complexity of building a system 
that can retain cargo and release it in the presence of a certain trigger requires specific 
functionality to be post-synthetically added to the scaffold. After synthesizing the desired 
scaffold, the exterior and/or interior can be functionalized with the condensation of 
organosilanes of the type (RˈO)3SiR onto the MSN surface, allowing for a broad range of 
functionalities to be added, depending on the application.52  
There are a variety of ways to post-synthetically control the location of the 
organosilane. If modification with the same organosilane is desired on both of the exterior 
and interior, removal of the interior surfactant template through calcination is performed. 
This allows the organosilane to modify the exterior surface and the now opened interior 
pore surface of the material. To modify the exterior surface and interior surface 
differentially, the surfactant can be retained, blocking the pores of the material and limiting 
the amount of organosilane entering the material. After grafting, the removal of surfactant 
can be accomplished through an extraction process, exchanging the surfactant with an 
appropriate solvent. With the opening of the pores of the material, a second grafting process 
can proceed adding a separate organic functionality to the interior pore surface.42, 67  
 Interior (pore) modification has several advantages for controlling the loading and 
release of cargo. Depending on the physical and electrostatic characteristics of the cargo, 
the degree of interaction can be easily manipulated. Some systems require a strong 
interaction (covalent bonding, electrostatic interaction versus weak interactions (hydrogen  
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bonding and/or physical adsorption) of the interior and cargo to control aspects of the  
delivery kinetics and rate of diffusion from the interior pore volume.42, 68-70  Manipulating 
the interior separate from the exterior allows for tailoring of the material for the cargo that 
will be loaded and released from the system. The only limitations of interior modification 
are controlled by the ability of the silane to enter the interior pore system and the degree of 
modification. Depending on the size of the silane, pore diameter can limit the organosilane 
that can be introduced into the interior of the material. Additionally, organosilane 
modification has to be controlled to limit the propensity for pores to become blocked by 
extensive modification.52 
 Exterior modification of MSNs has been at the forefront of research on the 
tailoring of the material to interact with its external environment. Depending on the type 
of external trigger that is required to release the cargo, exterior modification plays an 
important role in helping to retain the loaded cargo. This has expanded the development of   
a “gating” systems in which access to the pores is restricted by blocking or modifying the 
pore to entrap the loaded cargo.  
1.3.4. MSN Gating for Triggered Delivery of Cargo 
Gating is a specific modification approach that restricts access to the pore of the 
MSN, acting as a “gate”. Gating can be separated into three main categories based on the 
method of retaining the cargo. The first is based on the direct attachment of the cargo to 
the interior surface of the material through coordinate or covalent attachment. This allows 
retention and transport of the cargo until the presence of the trigger, which can be a 
reducing agent,71-73 light,74-78 a pH change,75-76 or a temperature change,79-81 such as with  
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the functionalization of a MSN with an azobenzene derivative that will undergo a cis-trans 
photoisomerization induced by light at 413 nm. The switch from cis to trans causes a 




Figure 1.7: Release of cargo by cis-trans photoisomerization. 77 
 
Another approach to a gating system has been to fully coat the exterior surface to 
block the pores. Coating can be accomplished with a variety of materials such as 
polymers,19, 82-85 polyelectrolyte mulitilayers86-87 or biomolecules.88-90  The release of the 
coatings from the surface of the MSNs allows for the loaded cargo to escape. The trigger 
can be based on changes in pH,82, 85-87 temperature,19, 82, 84-85 chemical environment88 or on 
molecular recognition using enzymes83 or competitive molecules.89-90 This has been seen  
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by exterior surface functionalization with the long chain polymer, poly(N-
isopropylacrylamide). At a temperature of 25°C, the chain is extended to allow for the 
loading of cargo. Increasing the temperature to 35°C, the chain is in a coiled confirmation, 
blocking the pores and retaining the loaded cargo until a decrease in temperature (Figure 
1.8).84   
 
 
Figure 1.8: Coating approach to gating of MSN using a temperature sensitive poly(N-
isopropylacrylamide).84 
 
The third gating method involves the direct blocking of the pore with a bulky 




100) or long chain molecules (polyamine101-102). The introduction of an external 
stimulus such as light,28-29, 96 pH,14, 91-92, 94-96, 99-102 enzyme,33, 93 magnetic field98 or reducing 
agents27, 97 results in the loss of the pore blockage and subsequent release of the cargo. This 
has been seen with blocking the pores with carboxylic acid-modified cadmium sulfide 
nanoparticles (CdS). Modification of the interior pore of the MSN with a long-chain amine,  
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containing a disulfide bond, allows for a peptide coupling between the CdS and MSN. This 
allows for entrapment of the loaded drug until the introduction of dithiothreitol (DTT) to 
cleave the disulfide bond, releasing the CdS, and opening the pores (Figure 1.9).97 
 
 
Figure 1.9: Direct blocking with a CdS nanoparticle with a reducing agent sensitive disulfide bond.97 
 
Gating systems have an advantage over previous triggered-release systems that 
rely on simply changes in temperature, pH, or chemical environment. Gating allows for 
molecular recognition systems to control the release of molecular cargo from the MSN. 
This has been seen with the example of glucose oxidase tethered to an MSN surface 
through an enzyme-inhibitor interaction to retain the loaded Rhodamine B cargo. In the 
presence of the desired enzyme substrate (glucose), glucose oxidase is released from the 
surface to break down glucose, opening the pores of the material (Figure 1.10).103  
Narrowing down the release-trigger to a specific molecular recognition interaction reduces  
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the potential for premature release of the molecular cargo. This has led the use of these 
systems in areas in which specificity is essential, such as detection.104-105   
 
 
Figure 1.10: Molecular recognition controlled by recognition of substrate (glucose) by the degrading 
enzyme (glucose oxidase).103 
    
1.4. Detection Through Gating Systems 
An emerging category of the application of gating systems to the problems of 
molecular detection and sensing, specifically on the design of small-molecule based 
systems.106-108 Free standing small molecule-based sensors have been widely used but 
several drawbacks have pushed for the integration of these systems within solid supports. 
A solid support allows for greater stability of the sensor and additional functionalization 
can be added to create a more effective detection system.25 Integration into solid supports 
has been applied to the detection of a variety of analytes such as ions,109 biomolecules,107 
explosives108 and pesticides.110  
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1.4.1. Molecular Recognition 
 The goal of developing more complex detection systems is generally to enhance 
the sensitivity of the system. The use of molecular recognition systems, where the response 
is based on a specific molecular interaction, can lead to sensitive detection systems.104-105 
These are often based on biomolecules such as enzymes, amino acids, or nucleic acids. For 
example, the affinity of an enzyme for its substrate, can be built into a detection system, 
drastically increasing its sensitivity. In particular, this has been the trend in the 
development of biosensors for the detection of organophosphate pesticides.   
1.4.2. Organophosphate Detection 
 Organophosphate detection and decontamination has continued to be an evolving 
field of research. Ranging from less toxic pesticides to extremely toxic nerve agents, 
organophosphorus compounds can have detrimental effects, in which the structural 
features will be discussed in Chapter 4. The neurotoxicity of these compounds arises from 
their inhibitory effect on acetylcholinesterase (AChE). AChE is responsible for the 
hydrolysis of acetylcholine (ACh), a neurotransmitter used in neuronal communication 
(Figure 1.11).111-112 Exposure to an organophosphate results in the phosphorylation of a 
serine residue within the catalytic site of AChE. This inhibits the ability of AChE to 
hydrolyze ACh into choline and acetate, causing a buildup of ACh in nerve synapses and 




Figure 1.11: Acetylcholinesterase (AChE) and its active site in the presence of acetylcholine (ACh).111-
112 
  
Past methods for the detection of organophosphates have consisted of 
instrumental techniques such as gas chromatography, mass spectrometry, and NMR 
spectroscopy. While these techniques offer low detection limits, problems with portability, 
real-time and complex use, and false positives remain. 115-125 To address some of these 
issues, research has shifted towards the development of colorimetric38-39 and fluorimetric39-
40 response systems, deriving from previous extensive use in small molecule detection. 106, 
126-128  Optical response systems offer a rapid, highly portable, and quantitative detection 
method, often using only the naked eye. This helps to address issues of real-time and ease 
of use of these systems by military personnel and civilians. 38-39, 129 
1.4.2.1. Optical Biosensors 
The development and use of optical biosensors for organophosphate detection 
covers a broad range of detection strategies. These strategies can be categorized by the 
triggering response method, whether inhibition or catalysis. (Each mechanism activates a  
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secondary action, giving the optical response). In triggered systems, using catalysis, the 
use of a bacterial enzyme capable of hydrolyzing organophosphotriesters allows specificity 
to be controlled by a substrate-enzyme interaction. Two of these bacterial enzymes are 
organophosphorus acid anhydrolase (OPAA) and organophosphorus hydrolase (OPH). 
OPAA has a high specificity for hydrolysis of P-F and P-CN bonds, which are present in 
the nerve agents sarin and tabun but cannot hydrolyze P-O or P-S bonds that are present in 
pesticides such as parathion, malathion, and demeton-s. 
OPH has the ability to hydrolyze a wide variety of organophosphorus compounds 
through the cleavage of the P-O, P-F, P-S or P-CN group, with the catalytic rate dependent 
on the bond.130-131 After the hydrolysis reaction, the production of an acid (XH) and alcohol 
offer a variety of ways in which to optically activate the biosensor. The acid can trigger a 
response from pH-sensitive dye, whereas the alcohol is often chromophoric, and can be 





Figure 1.12: Reaction scheme for the OPH-catalyzed hydrolysis of organophosphates.132 
  
Inhibition-based biosensors for organophosphates require the use of 
cholinesterases such as AChE. The activity of AChE hydrolyzing ACh is measured and 
compare to the activity of AChE after exposure to an organophosphate. The 
organophosphate will phosphorylate the active site of AChE, preventing hydrolysis of 
ACh, and slowing the hydrolysis rate. This allows the tracking of AChE activity and its 
inhibition by secondary process to give an optical signal.129 The sensitivity of AChE to 
organophosphates has been routinely explored, most notably by the widely used 
colorimetric method for tracking the activity of AChE, the Ellman’s method. The Ellman’s 
method tracks the hydrolysis of acetylthiocholine (AtCh) to its product, thiocholine (tCh) 
that reacts with the Ellman’s reagent, 5,5-dithio-bis-(2-nitrobenzoic acid), to give a color 
product (2-nitro-5-thiobenzoate) that can be tracked by UV-Visible spectroscopy.133-134 
 While each approach for the primary mechanism of the biosensors has shown  
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several benefits, they are still based on secondary signals. This limits the benefits of having 
an optical system that can effectively notify an individual of the presence of a toxic 
substance, where time is crucial. This flaw has pushed organophosphate detection in new 
directions that continue the use of an optical detection method but rely on a direct response 
to an organophosphate. 
1.5. Rationale for This Study 
The rationale for this study is that the use of a molecular recognition system for 
organophosphate detection will eliminate the problem of false positives seen with previous 
detection systems. To do this, the use of a MSN as the scaffold to contain the optical signal, 
the dye Congo Red, is capped with an enzyme to block the pores to retain the loaded dye. 
The mode of attachment of the enzyme (OPH or AChE) was through the use of a 
competitive inhibitor of the enzyme. Testing of the triggered-release mechanism with 
either substrate or organophosphates was thoroughly explored to test the stability of the 
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CHAPTER 2: SIMULTANEOUS DETECTION AND DECONTAMINATION OF 




 Organophosphorus compounds have an expansive toxicity range from pesticides 
to chemical warfare agents (CWAs), specifically nerve agents. Neurotoxicity arises from 
the inhibitory effect on acetylcholine esterase that causes buildup of acetylcholine in nerve 
synapses resulting in paralysis and death.1-7 The extreme toxicity and extent of destruction 
nerve agents can and do have caused resulted in part the development of the Chemical 
Weapons Convention. This was an agreement to stop the production and eliminate 
stockpiles of all CWAs but the continued exploitation during conflicts has persisted.8-9 The 
recurrent threat of exposure to military organizations and the general public within conflict 
zones has continued the effort towards the design of more effective detection and 
degradation systems. 
 Detection of nerve agents has been at the forefront of detection and degradation 
systems. The ease of exposure and the severity of toxicity have driven this area to include 
a wide range of detection methods. The major drawback of these systems has been 
problems with portability, real-time and complex use, and false positives.7, 10-19 To address 
some of these issues, a shift towards the use of colorimetric3-4 and fluorimetric4-5 response 
systems has been seen.  Optical response systems offered a rapid detection method, often  
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using only the naked eye as the detector. Though these systems have complications with 
false positives even now. 3-4 
 While detection of toxic organophosphorus compounds has seen progress, 
degradation of these species is equally as important. There are several different methods 
that have been developed to destroy or degrade CWAs including incineration, hydrolysis 
or oxidation.19-20 Often though, these degradation methods result in problems such as the 
transportation of the CWA’s to only a few incineration plants and the use of toxic or 
corrosive chemicals such as bleach that further hinder decontamination.2, 19, 21 A way to 
circumvent these problems is through the use of enzymes to degrade certain CWAs.2 
Enzymatic degradation of organophosphorus pesticides and nerve agents (Figure 2.1)20 
has been performed with organophosphorus hydrolase enzymes (OPH).2, 6, 22-26 The general 
scheme for deactivating organophosphorus compounds is through the hydrolysis of  P-S, 
P-O, P-F, and P-CN bonds.22, 27 
 
 




While there has been great advancement in the areas of detection and 
decontamination separately, ideally, an all in one detection and decontamination system is 
desired. When considering the use of these systems in real-world applications, it is much 
more efficient to have a dual system. There are several aspects to consider when designing a 
dual system such as who is using this system, how effective is it and how much does this 
system cost. The goal of the current system addresses these issues by having a visual 
detection system that is easily discernable by an individual without specialized training, 
costs kept low by using a scaffold that can be produced in large quantities and utilizing a 
dual detection and decontamination system for increased efficiency.  
 The use of OPH as an efficient decontamination method has shown promise. 
Using an enzyme to accomplish the degradation of organophosphorus compounds has 
many advantages over the other common methods of degradation. The use of OPH allows 
for fast and efficient catalytic hydrolysis without leaving further toxic byproducts. This 
makes the system environmentally friendly and allows the system to be easily transported 
to areas that have been contaminated. The only complications with using an enzyme are 
their tendency to denature, however this can be avoided through immobilization.28  
 For the detection method for this system, visual indication will be used to keep  
the system easy to use. By only having to use the naked eye as a detector, portability is  
possible without the use of a physical detection system. There are a wide range of dyes  
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that can be used to give a quick response that the decontamination process is occurring. 
To combine the detection and decontamination aspects, porous silica can be used 
as a scaffold to integrate these two systems. Using a porous silica support, specifically 
mesoporous silica, has several advantages. Immobilization will help prevent denaturation 
of OPH to extend the lifetime and has even been shown to increase the activity of OPH.23, 
28 The large range of pore diameters (2-50 nm), large surface areas (300-1500 m2g-1) and 
surfaces that can be easily functionalized, allows the mesoporous silica to be tailored.28-30 
 Utilization of the mesoporous silica scaffold will begin by first loading dye into 
the interior pore volume of the mesoporous silica to which OPH can be immobilized onto 
the silica surface. This serves a dual functionality of blocking the pores to keep the dye in, 
as well as decontaminating organophosphorus compounds upon its triggered release. To 
temporarily hold OPH to the surface, a competitive inhibitor of OPH can be used and will 
release OPH when in the presence of an organophosphorus compound (Figure 2.2). This 
system would offer an effective detection and decontamination method that is easily 




Figure 2.2: A model of simultaneous detection and decontamination of organophosphorus 
compounds.  
 
2.2. Experimental Section 
2.2.1. Materials and Instrumentation 
 All materials were purchased from Sigma-Aldrich, VWR and Life Technologies, 
unless otherwise noted. Nuclear Magnetic Resonance (NMR) spectra were recorded on a 
Bruker AVANCE III 500 MHz high-field NMR spectrophotometer with a multi nuclear 
observation capability. UV/Vis spectra were measured using a Perkin-Elmer Lambda 35 
spectrophotometer system. Thermogravimetric analysis (TGA) was performed on a 
PerkinElmer Pyris 1 DSC-TGA. Scans were performed under a mixed flow of nitrogen 
(85%) and oxygen (15%) between 25 °C and 800 °C at 20 °C/min with a thermal hold at 
100°C for 15 minutes to get rid of water. N2 adsorption and desorption isotherms were 
obtained on a Micromeritics TriStar instrument. Surface areas were measured using the 
Brunauer-Emmett-Teller (BET) method and pore size distributions were calculated from a 
modified Kruk, Jaronic and Sayari (KJS) method using the adsorption branch. 
2.2.2. Synthesis, Functionalization and Characterization of APMS 
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2.2.2.1. Synthesis of Acid-Prepared Mesoporous Silica (APMS)  
 APMS was synthesized as previously described. 31-32 
2.2.2.2. Synthesis of APMS-(s)-NH2  
 Pore-blocked APMS (1.8 g) was suspended in hexanes (400 mL) to which 3-
aminoproplytriethoxysilane (APTES) (1.8 mL) was added. The solution was refluxed for 
3.5 hours under an inert atmosphere (N2) to form the product APMS-(s)-NH2. To remove 
surfactant from the pores, APMS-(s)-NH2 was extracted by refluxing with acidified ethanol 
(0.1 M HCl in ethanol) for 24 hours (3X), filtering and letting dry between each cycle. The 
degree of modification was characterized by thermogravimetric analysis (2.02 mmol 
modification/g APMS) and the physical properties characterized by nitrogen physisorption. 
The resulting APMS was then placed under vacuum to keep dry until further modification. 
2.2.2.3. Synthesis of APMS-(s)-NH-COOH  
 Extracted APMS-(s)-NH2 (1.5 g) was suspended in acetonitrile (dry) under an 
inert atmosphere (N2) to which triethylamine (950 µL) and succinic anhydride (355 mg) 
was added. The solution was stirred at 60°C for 21.5 hours then collected by vacuum 
filtration. Several washings with trifluoroacetic acid (0.1% in water) and acetonitrile were 
followed by drying overnight. The degree of modification was characterized by 
thermogravimetric analysis (0.606 mmol modification/g APMS) and the physical 
properties characterized by nitrogen physisorption. The resulting APMS-(s)-NH-COOH 
was then placed under vacuum to keep dry until further modification. 
2.2.2.4. Synthesis of APMS-(s)-DEABP  
 To 200 mg APMS-(s)-NH-COOH suspended in 40 mL MES buffer (50 mM, pH  
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= 6.0), N-hydroxysuccinimide (10, 28 or 50 mg) was added and stirred at room temperature 
for 20 minutes. To this solution N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (22, 55 or 90 mg) was added and stirred an additional 2.25 hours. A solution 
of diethyl 4-aminobenzyl phosphonate (DEABP) (20, 53 or 78 mg) in acetonitrile (dry, 1 
mL) was then added slowly and stirred for 21 hours. The particles were collected by 
vacuum filtration and washed with deionized H2O and acetonitrile and left to dry overnight. 
The degree of modification (0.151, 0.214, 0.414 mmol modification/g APMS, respectively) 
was determined by thermogravimetric analysis and the physical properties characterized 
by nitrogen physisorption. The resulting APMS-(s)-DEABP was then placed under 
vacuum to keep dry until further modification. 
2.2.2.5. Synthesis of APMS-(s)-DEABP-OPH  
 To 5 mg APMS-(s)-DEABP suspended in 425 µL CHES buffer (20 mM, pH = 
9.0), 175 µL OPH (453 µg/mL) was added and placed on a rotating platform for 
 21.75 hours. The sample was centrifuged, supernatant removed and immobilized OPH 
determined. The particles were washed with CHES buffer (3X) and re-suspended in the 
appropriate amount of CHES buffer for kinetics testing. Free OPH concentrations and 
amounts of OPH immobilized onto APMS-(s)-DEABP were calculated using the Bradford 
method (reference in main text) from a standard bovine serum albumin (BSA) calibration 
curve. Triplicate samples measured for standard curve. 
2.2.3. Measurement of Enzymatic Activity. 
2.2.3.1. 31P NMR Assay  
 Samples were spun at 20 rps at 25 °C and 31P shift was referenced to external  
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H3PO4 shift standard at 0 ppm. A 90° phosphorous pulse prior to acquisition was used to 
give maximum signal response for shorter acquisition time. An aliquot of deuterium oxide 
(50 µL) was added to each sample after the reaction was terminated but before transfer to 
the NMR tube for a field lock. A 100 ppm sweep width was used with approximately 20-
200 scans depending on the conversion rate of the reaction. 
2.2.3.2. Degradation of Paraoxon by Free OPH  
 To CHES buffer (20 mM, pH= 9.0, 440 µL), CoCl2 (1.25 mM, 20 µL) and OPH 
(2.5 µg/mL, 20 µL) were added. A paraoxon stock (301 mM in methanol) was prepared 
and an aliquot added to give varying concentrations of paraoxon (2.45- 6.14 mM) in the 
solution and the time recorded. The sample was shaken for two minutes at which time OPH 
was denatured using sodium dodecyl sulfate (0.3 M, 50 µL). Each sample was run in 
triplicate and the enzymatic activity determined using 31P NMR with a phosphoric external 
standard. 
2.2.3.3. Inhibition of Free OPH by DEABP  
To CHES buffer (20 mM, pH= 9.0, 440 µL), CoCl2 (1.25 mM, 20 µL) and OPH 
(0.05 µg) were added. A stock solution of DEABP (100.5 mM) was prepared to which an 
aliquot was added to give varying concentrations of DEABP (16.4, 24.6 and 30.8 mM) in 
the reaction. The sample was shaken for five minute and then from a paraoxon stock (301 
mM in methanol), an aliquot was added to give varying concentrations of paraoxon (2.45- 
6.14 mM) in the reaction and the time recorded. The sample was shaken for two minutes 
at which time OPH was denatured using sodium dodecyl sulfate (0.3 M, 50 µL). Each  
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sample was ran in triplicate and the enzymatic activity determined using 31P NMR with a 
phosphoric external standard. 
2.2.3.4. Degradation of Paraoxon Using APMS-(s)-DEABP-OPH  
 To CHES buffer (20 mM, pH= 9.0, 440 µL), CoCl2 (1.25 mM, 20 µL) and APMS-
(s)-DEABP-OPH (0.05 µg OPH total) were added. From a paraoxon stock (301 mM in 
methanol), an aliquot was added to give varying concentrations of paraoxon (2.45- 6.14 
mM) in the reaction and the time recorded. The sample was shaken for 2 minutes at which 
the entire reaction mixture was filtered using a 0.2µm nylon membrane (25 mm) syringe 
filter. Each sample was run in triplicate and the enzymatic activity determined using 31P 
NMR with a phosphoric external standard. 
2.2.4. Congo Red Loading and Release Using OPH-Tethered Particles 
2.2.4.1. Loading of Congo Red (APMS-CR-(s)-DEABP)  
 Congo Red (CR) (51.9 mg) was added to a citrate buffer (10 mL, 0.1 M, pH 2.3) 
to make a CR stock. In a typical loading procedure, APMS-(s)-DEABP (11.5 mg) was 
shaken (20 hr) with the CR stock (5 mL, 7.45 mM). The sample was centrifuged and the 
supernatant measured by UV-vis to determine the amount of CR loaded. The material  
was washed once with CHES buffer (20 mM, pH= 9.0) to prepare for loading with OPH. 
2.2.4.2. Loading OPH (APMS-CR-(s)-DEABP-OPH)  
 To 11.5 mg APMS-CR-(s)-DEABP suspended in 400 µL CHES buffer (20 mM, 
pH = 9.0), 200 µL OPH (818 µg/mL) was added and placed on a rotating platform for  
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21.75 hours. The sample was centrifuged, supernatant removed and immobilized OPH 
determined. The particles were washed with CHES buffer until all non-encapsulated CR 
was removed.  The particles were then re-suspended in the appropriate amount of CHES 
buffer for kinetics testing. 
2.2.4.3. Release of Congo Red from APMS-CR-(s)-DEABP-OPH  
 In a typical reaction, to CHES buffer (20 mM, pH= 9.0, 1185 µL), CoCl2 (1.25 
mM, 60 µL) and APMS-(s)-OPH-DEABP (25.5 µg OPH total) were added. Testing using 
cell culture media was a 10% Fetal bovine serum (FBS) in Dulbecco’s Modified Eagle 
Medium (DMEM) (no phenol red, glutamine or glucose, pH 7.4).  A typical reaction 
sample, unless noted otherwise, was shaken for 15 minutes, centrifuged and supernatant 
measure to show no CR releasing. An aliquot of paraoxon was then added 
resulting in final concentrations of paraoxon (1.66 – 8.28 mM). The sample was shaken for 
five minutes, centrifuged, supernatant measured and particles re-suspended. This process 
was repeated every five minutes for a total of 35 minutes unless otherwise noted. The 
amount of CR released was determined by UV-vis based on a calibration curve. 
 
2.3. Results 
2.3.1. 31P NMR Assay of OPH Activity  
 Since 31P NMR can be applied to a broad spectrum of organophosphorus 
compounds, it is a useful technique in comparing the activity of OPH with respect to 
various substrates. Although UV-Visible spectroscopy (UV-Vis) is somewhat simpler, it  
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requires the substrate to contain a chromophore, therefore it is only applicable to a subset 
of compounds. Similarly, gas chromatography techniques can be a problem for low 
volatility substrates. In contrast, 31P NMR can be used for a wide variety of compounds, 
and the chemical shifts of the substrates and their hydrolyzed products are typically well-
separated. As has been shown in our previous experiments, the integrated areas of the 
paraoxon peak at -6.45 ppm and diethyl phosphate peak at 0.80 ppm can be referenced to 
an internal standard (phosphoric acid, d = 0.00 ppm, inserted into the NMR sample in a 
sealed capillary), and ratios of the peak areas can then be used to give the percent 
conversion of the substrate. Removal of aliquots from the enzyme-substrate reaction 
solution at various points during the conversion process followed with a Lineweaver-Burk 
double-reciprocal plot, which in turn is used to extract information about the activity of 
OPH. In this manner, 31P NMR was used to measure OPH activity in all of our experiments. 
2.3.2. Inhibition of OPH Using DEABP  
 To determine the type of inhibition exhibited by DEABP, free OPH (i.e. not  
attached to a particle surface) was exposed to DEABP at several concentrations (16.4, 24.6 
and 30.8 mM) in CHES buffer for five minutes, and then the activity of OPH toward 
paraoxon was determined by 31P NMR (Figure 2.3). This was compared to the activity of 
OPH in the absence of DEABP with all samples (with or without inhibitor) containing the 




Figure 2.3: Lineweaver-Burk plots comparing competitive inhibition by tethered and free DEABP. 
  
2.3.3. Preparation and Characterization of APMS-(s)-DEABP 
Construction of the inhibitor-tethered substrate was accomplished as shown in 
Figure 2.4. First, as-prepared APMS (i.e., with surfactant remaining in the pores) was 
reacted with 3-aminopropyltriethyoxysilane (APTES). The surfactant was then extracted 
in HCl/EtOH to open the pores of the substrate, and the primary amine was reacted with 
succinic anhydride to produce a carboxylate-terminated surface. Standard peptide coupling 
methodology was then used to tether DEABP to the particle surface at three different 
concentrations. The resulting materials are designated APMS-(s)-DEABP (low), -DEABP 
(med), and -DEABP (high). 
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Figure 2.4: Synthesis of APMS-(s)-DEABP. 
 
Thermogravimetric analysis (TGA) and N2 physisorption (Table 2.1) were used to 
characterize the physical properties of the materials at each stage of modification. To 
provide a basis for the calculation of the amount of organic modification of each material, 
a portion of the initial batch of APMS was calcined to completely remove the surfactant. 
This represented the maximum possible porosity of the material. The surface area of the 













APMS (calcined) 385 0.89 11 -- 
APMS-(s)-NH2 (extracted) 270 0.62 11 2.02 
APMS-(s)-NH-COOH 233 0.54 9.1 0.61 
APMS-(s)-DEABP-(low) 238 0.53 9.1 0.15 
APMS-(s)-DEABP-(med) 192 0.43 8.5 0.21 
APMS-(s)-DEABP-(high) 178 0.40 8.6 0.41 
 
 
2.3.4. Inhibition Testing of APMS-(s)-DEABP-OPH  
 OPH was stirred with APMS-(s)-DEABP (low, med, and high) for 21.75 h, and 
the particles were washed with CHES buffer. The amount of OPH remaining was 
determined in each case by the Bradford Assay on the loading solution supernatant after 
centrifugation. The amount of OPH loaded was determined from the initial Bradford Assay 
on the loading solution. Each APMS-(s)-DEABP-OPH material loaded different amounts 
of OPH, so adjustments were made so that each reaction contained the same amount of 
OPH (0.05 µg OPH total).  Inhibition tests were then performed on the basis of the amount 
of immobilized DEABP, using the 31P NMR assay described above (Figure 2.3).  
2.3.5. Dye Release from APMS-CR-(s)-DEABP-OPH (Single Addition)  
 The loading of CR within APMS-(s)-DEABP (high) varied depending on the  
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material, but a typical loading was 0.168 mM dye/mg particles that resulted in a deep red 
coloring (Figure 2.5). A control experiment was conducted to determine the amount of CR 
that would release without OPH capping the pores. After loading, APMS-CR-(s)-DEABP 
was washed extensively CHES buffer, centrifuging and re-suspending in fresh CHES each 
time. It was then shaken for one hr and supernatant measured by UV-Vis for any CR in 
solution. This was repeated for a total of five cycles until no further CR could be detected 
by UV-Vis. The particles were now faint pink in color and were dried under vacuum and 
TGA performed. There was approximately 15% of CR left in the particles that could not 
be removed.   
 OPH was then added as described previously, to form APMS-CR-(s)-DEABP-
OPH. Before paraoxon was used to test the complete detection and decontamination 
system, the particles were shaken for 15 minutes and the supernatant measured to ensure 
no CR was releasing. A 2.5 µL aliquot of paraoxon was added, resulting in a paraoxon 
concentration of 8.28 mM in the system. The concentration of dye in the supernatant was 
measured every five minutes to track the release of CR after triggered release of OPH using 




Figure 2.5: Congo Red release at several concentrations of paraoxon. 
 
 This was repeated with three additional concentrations of paraoxon 6.63, 3.32 and 
1.66 mM. The release profiles were plotted and fit as pseudo-first order association kinetics 
to determine the initial release rates and maximum (plateau) amount of dye released (Table 
2.2). A change of particle color from a deep red to a dark pink could be seen by the naked 
eye (Figure 2.5). 
 








8.28 2.26 28.3 
6.63 1.46 23.4 
3.32 1.14 10.1 
1.66 1.04 8.9 
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2.3.6. Dye Release from APMS-CR-(s)-DEABP-OPH (Multiple Additions)  
 APMS-CR-(s)-DEABP-OPH (high) was prepared as previously described. 
Compared to previous testing, more OPH (0.071 µg) was used compared to the previous 
experiments. To ensure that CR was not leaching from the particles, the supernatant was 
measured every four min before the first addition of paraoxon (6.63 mM in solution) after 
the 12 min measurement (Figure 2.6). Subsequent measurement of the supernatant by UV-
Vis tracked the release of CR. After the plateau (~20 min) and additional aliquot of 
paraoxon (6.63 mM in solution) was added after the 28 min measurement. The supernatant 
continued to be measured until the second plateau was reached (~48 min).  
 
 
Figure 2.6: Congo Red release with multiple additions of paraoxon (indicated by arrow).  
 
2.3.7. Dye Release from APMS-CR-(s)-DEABP-OPH (Recycling)  
To show the recycling ability of APMS-CR-(s)-DEABP-OPH, the material was 
sequentially exposed to paraoxon, 4.97 mM total in the system, with several washes with 
CHES buffer between exposures. This was to insure that the only measured dye would be 
released from the particles and not physisorbed (Figure 2.7). The amount of dye released  
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in the second test was approximately 60% of the original amount (3.3 vs. 5.5 µM). 
 
 
Figure 2.7: Sequential release of dye from APMS-CR-(s)-DEABP-OPH. 
 
2.3.8. Dye Release from APMS-CR-(s)-DEABP-OPH (10% FBS)  
 APMS-CR-(s)-DEABP-OPH was prepared as previously described. After the 
final wash with CHES buffer, the buffer was exchanged by washing three times with 10% 
FBS. The particles were shaken and centrifuged every five minutes and the supernatant 
measured by UV-Vis for 35 min to track any release of CR (less than 8 % of the total 
released). A 2.5 µL aliquot of paraoxon was added after the 35 min reading, resulting in a 
paraoxon concentration of 8.28 mM in the system. The concentration of dye in the 
supernatant was measured every five minutes to track the release of CR after triggered 
release of OPH using UV-Vis (Figure 2.8). With the addition of paraoxon, a large release 
of CR was seen with a rate of 0.41 µM/min with a maximum release (plateau) of 9.5 µM.  
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In comparison to previous experiments with a similar concentration of paraoxon (8.28 
mM), the amount of CR red released was about one-third that of the maximum release 
(28.3 µM).  The final supernatant was diluted 100-fold to measure the absorbance of the 
product peak (4-nitrophenol, 405 nm) to ensure that the hydrolysis of paraoxon occurred. 
 
 
Figure 2.8: Dye release in 10% FBS, pH 7.4. 
 
2.3.9. Dye Release from APMS-CR-(s)-DEABP-OPH (10% FBS) (Recycling)  
 After the previous release in FBS was completed, the material was washed several 
times with fresh FBS to remove any remaining paraoxon, CR or OPH (previously released). 
A second aliquot of paraoxon was added to give a total concentration of 0.3 mM of 
paraoxon. The hydrolysis of paraoxon was tracked by UV-Vis, measuring the absorbance 
of the hydrolysis product, 4-nitrophenol at 405 nm.  This was done every five minutes for 
30 minutes. This was then compared to a background hydrolysis of paraoxon in FBS over 
the course of 90 minutes (Figure 2.9). Using a calibration curve of 4-nitrophenol, the 
concentration of product in solution could be attained.  The tracking of the hydrolysis was  
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confirmed by recycling the material, as previously done, however using a lower 
concentration of paraoxon to easily track the hydrolysis product (Figure 2.9). This was 
compared to a background hydrolysis of paraoxon to ensure that conversion of the substrate 
was due to OPH and not by the other proteins within the culture media. The background 
conversion was minimal and appeared immediately after addition of the aliquot of 
paraoxon and held constant throughout the remaining measurements. 
 
 
Figure 2.9: Hydrolysis of paraoxon in 10% FBS, pH 7.4. APMS-CR-(s)-DEABP-OPH (blue); 




2.4.1. Selection of Scaffold  
The duality of a detection and decontamination system for organophoshates relies 
on the cooperation of several elements simulataniously within a self-contained system. The 
system presented has several parts that are controlled by the initial response to an 
organophosphate. This triggered response controls both parts of the detetection and  
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decontamination system by releasing OPH to decontaminate and the visual change to 
occur. The sensitiviy and speed of the system relies on the mechanism which releases OPH 
from the scaffold. This required a scaffold that could retain the activity of OPH and allow 
for the addtion of a visual indicator.  
 The use of APMS as the solid support for the self-contained system had several 
advantages. We23 and others33-35 have previously shown that the activity and thermal 
stability of OPH can be altered upon immobilization within the pores of mesoporous silica. 
Manipultion of the physical characteristics such as surface area and pore diameter allowed 
for the tailoring of the material for surface functionalization and dye loading and release. 
Larger pores (8-9 nm) permitted CR to easily enter and exit the interior volume of APMS 
and the exterior surface functionalized to readily accept OPH to trap CR inside. Preparation 
of the surface of APMS to temporarly hold OPH was the most important but challenging 
aspect of the system. OPH had to function as the decontaminat, as well as hold back the 
release of CR from the interior pore volume. The desired trigger for the release of OPH 
had to be more specific than a chemical or physical change in the reaction conditions to be 
a self-contained system. The temporary hold of OPH eluded to the possibility of using an 
inhibitor of OPH that could be displaced by the substrate, paraoxon. 
2.4.2. Selection of Inhibitor  
 In these studies, our goal was not to permanently immobilize OPH, but to tether 
it to the surface of a porous silica nanoparticles with an inhibitor that could be displaced 
upon recognition of a different organophosphorus substrate. There were several factors to 
consider when selecting the inhibitor, the most important of these was the type of inibition  
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it had on OPH. As the trigger, the inibitor had to be competitive to ensure that OPH would 
release and in the shortest amount of time. Noncompetitive and uncompetitive inhibitors 
would result in slow or no release of OPH and could decrease the rate of hydrolysis. Using 
an inhibitor that was similar in structure to paraoxon and had previously been found to be 
a competitive inhibitor36 was the starting point for probing its use as an immobilized 
inhibitor.  
 We chose diethyl-4-nitrophenyl phosphate (paraoxon) and diethyl-4-aminobenzyl 
phosphonate (DEABP) as the substrate and inhibitor for these experiments (Figure 2.10). 
OPH rapidly reacts with paraoxon, making it easy to determine enzyme activity. DEABP 
has a similar structure to paraoxon, but the p-nitrophenyl group is connected to the 
phosphorus atom through a carbon atom instead of an oxygen atom. This ensures that the 
hydrolytic cleavage of the p-nitrophenyl group cannot occur, although the molecule's size 
is similar to paraoxon. In addition, the terminal amine allows DEABP to covalently 
attached to the particle's surface with standard peptide coupling methodology. This would 
allow for the temporary holding of OPH to the surface of APMS in the absence of a 





Figure 2.10: Structures of the substrate and inhibitor used in these experiments. 
  
2.4.3. Type of Inhibition  
 To confirm the type of inhibition DEABP has with OPH, activity of OPH 
hydrolyzing paraoxon with and without DEABP were measured and plotted as 
Lineweaver-Burk plot. A Lineweaver-Burk plot is a useful tool to study enzymatic 
inhibition, because the effects of competitive and non-competitive inhibition produce 
graphically distinct results that are easily observed. In competitive inhibition, the y 
intercept (1/Vmax) remains the same in the presence of the inhibitor although the x intercept 
(-1/KM) decreases because the observed binding constant of the substrate changes in the 
presence of a competitive inhibitor, although at sufficiently high concentrations of 
substrate the maximum velocity of the reaction remains the same. The new x intercept, -
1/(1+[I]KI, where [I] = the concentration of inhibitor and KI is the dissociation constant of 
the inhibitor with respect to the enzyme, is sensitive to the concentration of inhibitor.3738 
(The results are shown in Figure 2.3) The y-intercept of all plots was identical, and the x 
intercepts of each plot decreased as the concentration of DEABP increased. This shows 
that DEABP is a competitive inhibitor of OPH, reversibly binding at the active site and 
being released at higher concentrations of paraoxon. 
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2.4.4. Synthesis of APMS-(s)-DEABP  
 The characterization of APMS-(s)-APMS was important to ensure that the design 
of the scaffold not only was correct but retained the desired structural characteristics. 
Characterization of the as-prepared APMS (calcined) confirmed an appropriate starting 
material for the final desired APMS-(s)-DEABP. A larger pore diameter was desired to 
compensate for the tightening of the pore diameter resulting from the organic 
functionalization. This allowed for the final pore diameter to be large enough for the dye 
to enter but more importantly allow for a faster release of dye from the interior pore volume 
without restriction.  The pore volume (0.89 cm3/g) of a material with this surface area and 
pore diameter suggested a porous material with highly interconnected pore structure, 
consistent with previous publications on APMS. This allowed for adequate volume for the 
dye to be held after addition of OPH to cap the pores.  
 The desired surface functionalization of APMS can be seen in Figure 2.11 
(Ideal). Each synthetic step factored into the number of potential inhibition sites because 
the degree of each modification is dependent on the previous. The goal of the amine 
addition was to thoroughly populate the surface of APMS to keep OPH on the surface of 
the particle, although some diffusion of APTES within the surfactant micelles is 
expected.38 Surface functionalization not only increases the potential of OPH to block the 
pores of the material but increases the potential for a faster triggered release. If 
functionalization occurred deeper within the mesoporous structure, the more problematic 
the diffusion of substrate would be to active site of OPH (Figure 2.11 A). Functionalization 
of the interior could also increase the surface charge to more positive due to the protonation  
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of the amine groups. Retention of the interior volume was also necessary for maximum dye 
loading needed to increase the potential amount and rate of dye released after loss of OPH.  
 
 
Figure 2.11: Conceptual influences on surface functionalization and OPH loading and CR releasing. 
 
TGA data used to show the extent of modification indicated that the external 
surface was easily modified with APTES, though because the amount of modification with 
succinic anhydride was less than the total amount of amines available (0.61 mmol/g versus 
2.02 mmol/g), not all of the amine groups reacted with succinic anhydride. However, 
coupling to DEABP appeared to be successful and controllable, with the amount of 
DEABP on the surface directly related to the amount used in the synthesis (Table 2.1). The 
capping of unreacted amine and succinic anhydride groups was found to not be necessary 
because it did not influence the inhibition of OPH or its release, shown later in activity  
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testing (Figure 2.11 B). The porosity of the material decreased after each modification, as 
indicated by the decreasing SABET, Vpore, and dpore in each step. This indicated that there 
was likely some modification not only of the external particle surface, but of the pore 
entrances as well. However, the amount of pore modification was not significant enough 
to completely close the pores, so that they could still be loaded with dye in a later step. 
2.4.5. Immobilization of OPH  
 The immobilization of OPH onto the surface of APMS-(s)-DEABP was 
controlled by many factors. An ideal material would have the maximum amount of OPH 
directly proportional to the amount of DEABP on the surface because of the single catalytic 
site of OPH (Figure 2.11 (Ideal)).36 Nevertheless, this does not account for other variables 
that influence the amount OPH that could be immobilized. The main restriction was the 
amount of OPH that could physically fit on the surface of APMS. A single OPH molecule 
is approximately 6.1 nm x 8.6 nm x 5.1 nm.39 If two inhibitor molecules were at a distance 
less than the smallest dimension (51Å), only one OPH would attach. This can be extended 
to the other dimensions of OPH, as well as the density of inhibitor on the surface.  
 The packing on the surface of APMS was also influenced by the size of the  
pores (8.6-9.1 nm) that were desired for the fast loading and release of dye.  To ensure that 
the pores would be effectively capped, two or more OPH molecules had to be in close 
enough proximity (Figure 2.11 C). Without the close packing on the surface, the dye would 
leach from the interior pore volume. As previously discussed, steps were taken to control 
the number of inhibitor molecules available but always exceeded the amount of OPH that 
attached (Table 2.3). This was to ensure that there was adequate surface coverage of OPH  
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on the surface (Figure 2.11 D). 











APMS-(s)-DEABP-(low) 2.49E-01 8.02E-02 2.66E-02 
APMS-(s)-DEABP-(med) 3.68E-01 1.02E-01 5.57E-02 
APMS-(s)-DEABP-(high) 2.47E-01 3.35E-02 7.25E-02 
 
 
2.4.6. Inhibition Testing of APMS-(s)-DEABP-OPH 
 With DEABP successfully tethered to the particle surfaces, we next confirmed 
that DEABP still acted as a competitive inhibitor of paraoxon after the tethering process. 
The Lineweaver-Burk plot (Figure 2.3) for tethered OPH shows that DEABP continued to 
act as a competitive inhibitor, because the y-intercept for the samples did not change when 
the amount of DEABP changed. What is quite interesting about this plot was that although 
the amount of tethered DEABP was much lower than that in tests using free DEABP (µM 
here versus mM in Figure 2.3), the slopes of the lines here are significantly larger. As 
described above, smaller concentrations of a competitive inhibitor are expected to show 
smaller slopes. This is likely due to a concentration effect produced by immobilizing the 
DEABP. When it is free, OPH must diffuse through solution between encounters with  
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DEABP. However, when the DEABP is tethered to a surface, its local concentration is 
much higher (Table 2.3), so the diffusion length between DEABP-OPH encounters is 
much shorter, and the effective inhibition of OPH is larger. Thus, it appears that when it is 
tethered to a surface, less inhibitor is required to achieve a significant inhibitory effect than 
if the inhibitor were dissolved in solution.40 This is evident in the calculation of the KI 
values for the free inhibitor (2.55 mM) versus immobilized (1.37 x 10-5 mM). The drastic 
decrease in KI for immobilized was attributed to the immobilization of the inhibitor the 
surface, locking it into a set orientation. Once OPH was in the correct orientation to bind 
the inhibitor within its active site, it was held tightly. Comparing this to the free inhibitor 
and free enzyme, the inhibitor was free to move about the solution allowing it to bind 
weakly within the active site. This results with the free inhibitor have a much larger KI. In 
terms of a triggered release system, the large slope indicates that the system is effective at 
very low concentrations of substrate and is sensitive to small chan,es in substrate 
concentrations. 
2.4.7. Dye Selection  
 We tested several dyes for use in this detection system, and found that optimizing 
hydrophobic and electrostatic interactions with the silica surface were critical factors. 
Some dyes bound to the silica particles tightly but would not be released in sufficient 
quantities once the pores were opened; others bound so loosely that not enough dye was 
loaded into the particles in the first place. After multiple experiments, Congo Red (CR) 
(pKa = 4.1, Figure 2.12) was selected as the detection dye because it could be loaded in 
significant amounts at pH = 2.3, where it was protonated and had a neutral charge, binding  
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weakly to the anionic surface of APMS.  
 Under the conditions used to allow the interaction of OPH with the surface-bound 
inhibitor (pH ≈ 9), the surface of APMS had a negative  potential due to the deprotonation 
of surface silanols.23 CR deprotonated at this pH and was now repelled from the pore 
surfaces, but the OPH-inhibitor interaction occurred faster than the release of the dye, so 
the majority of the dye remained trapped within the pores.  Control experiments showed 
the potential release of almost all of the CR with only about 15% remaining within the 
particles. This was attributed to the structural characteristics of the modified material. The 
interconnected pore system allows for loading deep within the pore system and pockets of 
differing surface charge. This retained a small amount CR permanently but the majority 
freely releasing. The particles were then washed several times to insure that any 




Figure 2.12: Structure and color of protonated and deprotonated forms of Congo Red. 
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2.4.8. Response of APMS-CR-(s)-DEABP-OPH to Paraoxon 
 Several experiments were first performed to test the response of the system with 
the ideal substrate, paraoxon. The release of OPH with a single, set concentration of 
paraoxon showed several key benefits of the system (Figure 2.5). One of the major goals 
of the system design was to visually indicate the presence of an organophosphate for ease 
of use in real-world applications. A change in color by the naked eye could be easily 
detected before and after exposure to paraoxon. The initial color of the material was deep 
red and the release of CR after exposure to paraoxon, resulted in a material that was 
noticeably lighter in color (dark pink) in a short amount of time. This allows for facile 
determination of the presence of an organophosphate without instrumentation and 
specialized training. The use of UV-Vis to quantify the CR release but helps to confirm not 
only the response time of this visual indication, but also lends to information about the 
response of the system in the presence of paraoxon.  
 Of the four concentrations tested (1.66, 3.32, 6.63, and 8.28 mM) a measurable 
signal could already be detected after only five minutes and the maximum signal (plateau) 
reached within 15-25 minutes, depending on the paraoxon concentration. This fast response 
resulted from the effective combination of having a competitive inhibitor as the trigger 
mechanism and the fast release of CR from the interior pore volume. This release profile 
also gives insight on the mechanism of the triggered release.  
 At lower concentrations (1.66 to 3.32 mM), doubling the paraoxon concentration 
only increases the amount of CR released from 8.9 to 10.1 µM (Table 2.1). Comparing 
this to doubling the paraoxon concentration from 3.32 to 6.63 mM, the amount of CR more  
  
 64 
than doubles, resulting from a large burst release. Once OPH is released from the surface, 
it is free to begin hydrolyzing any substrate molecules within its reach. With lower 
concentrations of paraoxon, there is less substrate to initially release OPH and what does 
release, quickly hydrolyzes the substrate so no further OPH is needed. With only a small 
amount of OPH releasing, the potential amount of CR released was limited by the pores 
that were now uncapped. With higher concentrations, there was a large amount of substrate 
initially that caused a larger amount of OPH to release from the surface. This resulted in a 
greater number of pores to be uncapped and resulted in a higher potential amount of CR 
releasing from the particles. The amount of CR released lead to the faster plateau of the 
lower paraoxon concentrations (~10 min), compared to the large initial burst but longer 
time until plateau (~20-25 min) due to the CR still releasing from the larger number of 
uncapped pores. 
The idea that the quick release of CR at low concentrations resulted from a small 
number of OPH enzymes leaving, would result with the potential to continue to release 
OPH and recycle the particles. In similar fashion to testing with a single aliquot of 
paraoxon, APMS-CR-(s)-DEABP-OPH was subjected to two aliquots of paraoxon while 
allowing the material to reach a plateau before the addition of the second aliquot (Figure 
2.6). The concentration of paraoxon (6.63 mM) added was adjusted to compensate for the 
larger amount of OPH used for the experiment. A larger ratio of OPH to paraoxon of the 
first aliquot allowed the equilibrium to be reached quickly (less than eight min) and the 
second aliquot of the same concentration added. This took a longer time to reach plateau 
(20 min) but the total amount of CR released with similar kinetics to that of the first plateau  
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of about 5 µM. The slower time to reach the plateau was attributed to the smaller number 
of OPH molecules on the surface of APMS-CR-(s)-DEABP-OPH after the first release, as 
well as competition with released OPH. Released OPH was still viable for hydrolyzing any 
further paraoxon entering the system. With the addition of more paraoxon, a temporary 
increase in the total concentration paraoxon prompted additional OPH to be released. This 
resulted in the increase of CR similar to that seen with previous experiments with larger 
concentrations of paraoxon with a large initial burst and slower plateau. The temporary 
increase in paraoxon concentration was a result of the experiment itself in which the 
addition of paraoxon resulted from the plateau of CR, not the complete degradation of 
paraoxon. 
 The recycling of APMS-CR-(s)-DEABP-OPH was such that after exposure to an 
aliquot of paraoxon, the particles were washed, isolated and experiment performed again 
with an additional aliquot of paraoxon (Figure 2.7). The isolation and thorough washing 
of the particles ensured that the CR released would be from the second aliquot of paraoxon 
and not residual CR still releasing from the pores. It also ensured that any released OPH 
was fully removed from the solution and that OPH released would be only from the 
paraoxon used in the second cycle. Using the low (1.66 mM) and high (8.28 mM) 
concentrations of paraoxon as the boundaries, a mid-range concentration (4.97 mM) was 
used to probe the recyclability and determine the type of release at this range. The initial 
loading of CR in APMS-(s)-DEABP was lower than in previous samples which resulted in 
a lower plateau as compared to previous samples but the design of the system was still the 
same. This resulted in the expected release profile in which there was steady release of CR  
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that took longer than the lower concentrations of paraoxon but did not have the burst release 
as with the higher concentrations of paraoxon. This mid-range concentration also helped 
to ensure that there would be OPH still left on the surface for a second use. The second 
exposure to paraoxon showed a similar but slightly slower release profile. When the plateau 
was reached, the second cycle still released approximately 60% of the CR that the first 
cycle produced. This shows that there were still enough OPH-capped pores left after a 
single cycle the material could still produce a measurable signal within a short amount of 
time. 
2.4.9. Selectivity of Trigger  
 The final set of experiments was to test the selectivity of the system in the 
presence of cell culture media. Generally, FBS contributes to the cell growth and division 
by providing necessary of growth factors and other proteins in culture media.41 The use of 
this solution was to see if the designed triggered release system could differentiate between 
the variety of other proteins in solution and the desired substrate, paraoxon. To ensure that 
CR was released only by paraoxon, the APMS-CR-(s)-DEABP-OPH was first shaken and 
the supernatant measured to track any release of CR from the material, which was 
negligible in comparison to the release of CR after paraoxon addition (Figure 2.8).  
 Comparison of the ideal conditions to the cell culture media resulted in a 
maximum release concentration that was about 66% lower than under ideal conditions The 
ideal conditions were in CHES buffer at a more basic pH of 9.0, in which OPH is most 
active for the hydrolysis of paraoxon.42 Using FBS drops the pH to physiological 
conditions of pH 7.4, which lowers the rate of hydrolysis of paraoxon by OPH. This would  
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lead to a change in the release pattern of OPH from the surface of APMS-CR-(s)-DEABP-
OPH. The other contributing influence would be the other proteins that are present within 
the media. Interaction of paraoxon and APMS-CR-(s)-DEABP-OPH with these proteins 
(attraction and/or repulsion) will alter the rate at which OPH is displaced and the resulting 
release of CR.  
 Despite the lower release maximum of CR in culture media, the actual amount of 
CR released was more than sufficient to be easily detected and quantified. The ability for 
the system to differentiate between the desired substrate mixed within a system of a variety 
of biological proteins was attributed the design of the triggered release system. Using a 
competitive inhibitor based trigger allows for substrate specificity that is controlled solely 
by the enzyme, drastically improving the overall efficiency of the detection and 
decontamination system.  
 With confirmation that CR was releasing from APMS-CR-(s)-DEABP-OPH, the 
last step was to confirm that the OPH that was released continued with the hydrolysis of 
paraoxon. This could be easily obtained by measuring the UV-active hydrolysis product, 
4-nitrophenol. The concentration of 4-nitrophenol (Figure 2.9) for the background reaction 
that contained only paraoxon and FBS remained constant after an initial spike after addition 
of the paraoxon. This differentiated from the sample that contained APMS-CR-(s)-
DEABP-OPH, in which the hydrolysis reaction was evident by the increasing 
concentration of 4-nitrophenol over time. The increase in 4-nitrophenol proves that the 
OPH is still actively hydrolyzing paraoxon after the triggered release from the competitive 
inhibitor. This ensures that the release system does not deactivate OPH once released from 
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the surface in the presence of CR and that the other proteins within the cell media do not 
hinder the hydrolysis of paraoxon by OPH.  
 The use of this detection and decontamination system within physiological 
conditions adds in multiple factors that could have negatively affected the system from 
release of OPH without the substrate or prevention of CR release. The triggered release of 
active OPH from the competitive inhibitor proves the high substrate specificity of the 
system and the ease of the detection system by CR release shows the versatility of the 
 dual system, outside of ideal conditions.  
2.5. Conclusions 
 The detection and degradation of organophosphorus compounds is an important 
chemical and biochem research focus, because many of these compounds are neurotoxins 
that have been used as insecticides and stockpiled as chemical warfare agents. The ideal 
systems for this purpose would be triggered by the presence of the organophosphorus 
compound, decontaminate it, and give a visual response of this process. The use of APMS 
as the scaffold has several physical characteristics that can be tailored to support the 
decontaminate (OPH) and contain the detection element (CR) as a dual functioning system.  
 In the system described here, the interior pore volume of APMS was loaded with 
CR, and the exterior of particle was capped with an inhibited OPH that was released in the 
presence of a target organophosphorus compound. Specifically, the exterior of mesoporous 
silica nanoparticles was functionalized with diethyl 4-aminobenzyl phosphonate 
(DEABP). The competitive inhibition of OPH, both free in solution and immobilized 
DEABP, was confirmed through enzyme kinetics testing using 31P NMR. The competitive  
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inhibition was used as the trigger for the release of OPH, uncapping the pores and releasing 
of CR. Color change of the particles was used as visual indication, along with 
quantification by UV-Vis. This system worked with not only the ideal conditions, but 
within cell culture media containing a variety proteins and growth factors, 
 maintain the activity of OPH and detection of CR. 
 The use of a dual detection and decontamination system is beneficial not only in  
the realm of organophosphate disposal and protection but the mechanism in which the 
system is triggered. The concept of using the desired substrate as the trigger is ideal but 
often difficult to obtain. Utilization of a competitive enzyme-inhibitor pair allows substrate 
specificity to be built in to the trigger mechanism for a system that requires no additional 
influence, chemical or physical, to give a visual response. Extension of the use of this type 
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 The detection of organophosphorus compounds has grown into a broad field, with 
a variety of different ways to combat human exposure. The range of toxicity of these 
compounds, and their use in a variety of applications from military conflicts to agriculture, 
contribute to a range of possible exposure routes.1-8 The widespread impact of these 
compounds has pushed the need for organophosphorus detection methods to be faster, and 
easier for an untrained individual to use. Detection methods based on nanomaterials9-13 
have been increasingly useful in optical and electrochemical sensing systems, many based 
on assays measuring the activity of acetylcholinesterase (AChE).10  
 Organophosphorus compounds are toxic due to their irreversible inhibition of 
AChE by phosphorylation.1-8 AChE is responsible for the hydrolysis of the 
neurotransmitter acetylcholine (ACh), found within neural tissues. Inhibition of AChE 
leads to the buildup of ACh in neuronal gaps, preventing the neurons from returning to 
their resting states. 1-8, 14-15 The rate at which inhibition occurs is dependent on the chemical 
nature of the specific organophosphorus compounds (Figure 3.1)16 and is also dependent 






Figure 3.1: Binding of an organophosphorus compound (sarin) in the active site of AChE.16 
  
The use of optical response systems, specifically those based on colorimetric 
responses,3-4 have offered increased portability and ease of use with real-time detection.7, 
17-26 Many of these systems rely on the measurement of activity of AChE by tracking the 
hydrolysis of acetylthiocholine (AtCh) to its product, thiocholine (tCh).10, 27 Typically, 
Ellman's method has been used to detect tCh due to the formation of a colored product, 2-
nitro-5-thiobenzoate (yellow) with the addition of 5,5-dithio-bis-(2-nitrobenzoic acid) 
(Figure 3.2).27-28 One of the major drawbacks to this method is the use of additional 
chemicals or materials to induce these colorimetric responses based on a secondary 
response to the hydrolysis product. Many compounds can react with Ellman's reagent, 




Figure 3.2: Hydrolysis of AtCh by AChE and detection by the Ellman’s method to form a UV-Vis 
active product 2-nitro-5-thiobenzoate (yellow).27-28 
 
 
 Recent advances in the use of enzyme-modified nanomaterials in clinical 
diagnosis29-30 have highlighted the use of molecular recognition as an efficient way to 
increase sensitivity towards a specific substrate.30-31 Control of this recognition by the use 
of enzyme-specific inhibitors has been demonstrated, for example in the triggered release 
of an enzyme in response to substrate exposure.32 A molecular recognition system using a 
substrate-triggered release system based on the reversible inhibition of AChE would 
decrease false positives, due to substrate specificity. Combining this specificity with a 
direct visual response would result in a system that is easy to use with high sensitivity. 
 Our design of a system that combines a direct visual response with high sensitivity 
began by selecting a nanoparticle scaffold. The use of a porous silica support, specifically 
mesoporous silica, has several advantages. One key feature is that silica is easily modified 
with organosilanes to allow for attachment of an inhibitor, tacrine, to the surface, in turn 
allowing AChE to be immobilized.33-35 Tacrine has been commonly used as a competitive 
inhibitor of AChE and will hold AChE only temporarily, ensuring a fast release from the  
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surface of the particle. Tacrine also offers a primary amine that can be used to tether the 
inhibitor to the surface.8, 36-42 Immobilization of AChE not only helps to prevent 
denaturation but places the enzyme in a set confirmation to be released by substrate or 
organophosphate.33,43 Prior to introduction of substrate or organophosphate, 
immobilization of AChE on the surface will cap the pores of the mesoporous silica. 
Capping allows for the containment of a dye that can act as the optical response. After 
immobilization, inhibition of the AChE active site by an organophosphorus compound 
interferes with the AChE-tacrine interaction, triggering the release of AChE from the 
scaffold and resulting in the release of the dye (Figure 3.3). The proposed detection method 
offers a primary response system in which the signal of the system is in direct response to 
the substrate itself, giving high substrate specificity and limiting false positives.  
While similar to the system described in Chapter 2 using OPH, AChE will not be 
active after the release from the surface of the particle. Using AChE as a sacrificial enzyme 
offers several advantages over the OPH based system.  Sequential additions of paraoxon 
resulted in OPH actively hydrolyzing after releasing from the surface. After the first 
aliquot, any additional aliquots were primarily hydrolyzed by OPH free in solution. With 
phosphorylation of AChE, sequential additions of paraoxon will continue to release AChE 
from the surface. This resulted in testing the full concentration of each paraoxon aliquot 
and testing of system to trigger a false positive. Additionally, AChE was commercially 







Figure 3.3: A model of molecular recognition using inhibitor-enzyme triggered release system. 
  
 
3.2. Experimental Section 
3.2.1. Materials and Instrumentation 
 All materials were purchased from Sigma-Aldrich, VWR and Life Technologies, 
unless otherwise noted. UV/Vis spectra were measured using a Perkin-Elmer Lambda 35 
spectrophotometer system. Thermogravimetric analysis (TGA) was performed on a 
PerkinElmer Pyris 1 DSC-TGA. Scans were performed under a mixed flow of nitrogen 
(85%) and oxygen (15%) between 25 °C and 800 °C at 20 °C/min with a thermal hold at 
100°C for 15 minutes to remove any residual water. Nitrogen adsorption and desorption 
isotherms were obtained on a Micromeritics TriStar instrument. Surface areas were 
measured using the Brunauer-Emmett-Teller (BET) method and pore size distributions 
were calculated from a modified Kruk, Jaronic and Sayari (KJS) method using the 
adsorption branch. 
3.2.2. Synthesis, Functionalization and Characterization of APMS 
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3.2.2.1. Synthesis of Acid-Prepared Mesoporous Silica (APMS)  
 APMS was synthesized as previously described.43-44 
3.2.2.2. Synthesis of APMS-(s)-NH2  
 Pore-blocked APMS (1.8 g) was suspended in hexanes (400 mL) to which 3-
aminoproplytriethoxysilane (APTES) (1.8 mL) was added. The solution was refluxed for 
3.5 hours under an inert atmosphere (N2) to form the product APMS-(s)-NH2. To remove 
surfactant from the pores, APMS-(s)-NH2 was extracted by refluxing with acidified ethanol 
(0.1 M HCl in ethanol) for 24 hours (3X), filtering and letting dry between each 
cycle. The degree of modification was characterized by TGA (2.02 mmol modification/g 
APMS) and the physical properties characterized by nitrogen physisorption. The resulting 
material was then placed under vacuum to keep dry until further modification. 
3.2.2.3. Synthesis of APMS-(s)-NH-COOH  
 Extracted APMS-(s)-NH2 (1.5 g) was suspended in acetonitrile (dry) under an 
inert atmosphere (N2) to which triethylamine (950 µL) and succinic anhydride (355 mg) 
was added. The solution was stirred at 60°C for 21.5 hours then collected by vacuum 
filtration. Several washings with trifluoroacetic acid (0.1% in water) and acetonitrile were 
followed by drying overnight. The degree of modification was characterized by TGA 
(0.606 mmol modification/g APMS) and the physical properties characterized by nitrogen 
physisorption. The resulting APMS-(s)-NH-COOH was then placed under vacuum to keep 
dry until further modification. 
3.2.2.4. Synthesis of APMS-(s)-Tac 
To APMS-(s)-NH-COOH (128 mg or 57 mg) suspended in 15 or 8 mL  
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dimethylformamide (DMF), hydroxybenzotriazole (HOBt) (312, 82, or 42 mg), N, Nˈ-
diisopropylcarbodiimide (352, 90, or 48 mg) and 4-dimethylaminopyridine (DMAP) (16, 
4, or 1 mg) were added and stirred for 1 hour. Tacrine hydrochloride (Tac) (66, 14 or 7 mg) 
was then added and stirred for 19 hours. The particles were collected by vacuum filtration 
and washed with DMF and MeOH and left to dry overnight. The degree of modification 
(0.228, 0.281, 0.323 mmol modification/g APMS, respectively) was determined by TGA 
and the physical properties characterized by nitrogen physisorption. The resulting APMS-
(s)-Tac was then placed under vacuum to keep dry until further modification. 
3.2.2.5. Determination of [AChE] 
 Free AChE concentrations and amounts of AChE immobilized onto APMS-(s)-
Tac were calculated using a PierceTM BCA protein assay kit using a standard bovine serum 
albumin (BSA) calibration curve (reference in text). Triplicate samples measured for the 
standard curve. 
3.2.2.6. Synthesis of APMS-(s)-Tac-AChE  
 An acetylcholinesterase (AChE) stock (0.5 units/mL) in phosphate buffer (100 
mM, pH = 7.3) was diluted (195 µL AChE stock in 155 µL phosphate buffer). 280 µL of 
this solution was added to 2.5 mg APMS-(s)-Tac and shaken for 24 hours. The sample was 
centrifuged, supernatant removed and immobilized AChE determined. The particles were 
washed with phosphate buffer (3X) and re-suspended in the appropriate amount of  
phosphate buffer for kinetics testing.  
3.2.3. Measurement of Enzymatic Activity  
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3.2.3.1. Degradation of AtCh by Free AChE  
 To phosphate buffer (100 mM, pH = 7.3, 747.5 µL), Ellman’s reagent (20 µL) 
(reference in main text) and AChE (24.7 µg/mL, 5 µL, 6.8 ng per sample) were added. An 
acetylthiocholine stock (AtCh) (2.5 µL, 75 mM in deionized water) was prepared and an 
aliquot added to give varying concentrations of AtCh (0.24 - 1.38 mM) in the solution and 
the time recorded. The sample was shaken for 4 minutes at which time AChE was 
denatured using sodium dodecyl sulfate (0.3 M, 50 µL). Each sample was ran in triplicate 
and the absorbance peak of 2-nitro-5-thiobenzoate at 412 nm and the extinction coefficient 
(14250 M-1 cm-1) were used to determine kinetics. 
3.2.3.2. Inhibition of Free AChE by Tac  
 To phosphate buffer (100 mM, pH = 7.3, 747.5 µL), AChE (18.9 µg/mL, 5 µL, 
6.8 ng per sample) was added. A stock solution of Tac (9.34 µM) was prepared and an 
aliquot added to give varying concentrations of Tac (0.06, 0.12 and 0.30 mM) in the 
reaction.  The sample was shaken for five minutes and then from an AtCh stock (75 mM 
in deionized water), an aliquot was added to give varying concentrations of AtCh (0.24 - 
0.95 mM) in the reaction and the time recorded. The sample was shaken for 6-12 minutes 
at which time AChE was denatured using sodium dodecyl sulfate (0.3 M, 50 µL). Each 
sample was run in triplicate and were used to determine kinetics using the Ellman’s 
method.27 
3.2.3.3. Degradation of AtCh Using APMS-(s)-Tac-AChE  
 To phosphate buffer (100 mM, pH = 7.3, 1121 µL), APMS-(s)-Tac-AChE (6.8 ng 
AChE total) was added. From an AtCh stock (75 mM in deionized water), an aliquot was  
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added to give varying concentrations of AtCh (0.24 - 0.95 mM) in the reaction and the time 
recorded. The sample was shaken for 10 minutes and the entire reaction mixture was 
filtered using a 0.2 µm nylon membrane (25 mm) syringe filter. Each sample was ran in 
triplicate and were used to determine kinetics using the Ellman’s method. 
3.2.4. Congo Red Loading and Release Using AChE-Tethered Particles 
3.2.4.1. Loading of Congo Red (APMS-CR-(s)-Tac)  
 Congo Red (CR) (31.4 mg) was dissolved in a citrate buffer (5 mL, 0.01 M, pH 
3.98) to make a CR stock. In a typical loading procedure, APMS-(s)-Tac (4.2 mg) was 
suspended in a CR stock (3 mL, 9.01 mM) and shaken (20 hr). The sample was centrifuged 
and the supernatant measured by UV-Vis to determine the amount of CR loaded. The 
material was washed once with citrate buffer then with phosphate buffer (100 mM, pH = 
7.3) to prepare for loading with AChE. 
3.2.4.2. Loading AChE (APMS-CR-(s)-Tac-AChE)  
 A typical loading required 4.2 mg APMS-CR-(s)-Tac suspended in 950 µL 
phosphate buffer (100 mM, pH = 7.3), to which 250 µL AChE (499 µg/mL) was added and 
placed on a rotating platform for 24 hours. The sample was centrifuged, supernatant 
removed and immobilized AChE determined by the BCA assay. The particles were washed 
with phosphate buffer until all non-encapsulated CR was removed.  The particles 
 were then re-suspended in the appropriate amount of phosphate buffer for kinetics testing. 
3.2.4.3. Release of Congo Red from APMS-CR-(s)-Tac-AChE  
 In a typical reaction, phosphate buffer (100 mM, pH = 7.3, 950 µL) and APMS-
(s)-Tac-AChE (25.5 µg AChE total) were added. Testing using alternative solutions  
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included using cell culture media (10% Fetal bovine serum (FBS) in Dulbecco’s Modified 
Eagle Medium (DMEM) (no phenol red, glutamine or glucose, pH 7.4)) and 100% Human 
serum (male, AB plasma). Exchange of the AChE loading buffer with either FBS or human 
serum was performed by centrifuging and re-suspending the particles 3X to ensure full 
exchange into the new solution. A typical reaction sample, unless noted otherwise, was 
shaken for 15 minutes, centrifuged and supernatant measure to ensure no CR was releasing. 
An aliquot of substrate (paraoxon or AtCh) was then added, adjusting this volume for the 
desired final concentration in solution. This was shaken for five minutes, centrifuged, 
supernatant measured and particles re-suspended. This process was repeated every five 
minutes for 60 minutes unless otherwise noted. The amount of CR released was determined 
by UV-Vis based on a calibration curve.  
 
3.3. Results  
3.3.1. Ellman’s Method: Assay of AChE Activity  
 Ellman’s method has been widely used as a colorimetric method for the 
determination of AChE activity by quantifying the amount of tCh produced by the 
hydrolysis reaction of AtCh. The thiol containing product (tCh) reacts with the Ellman’s 
reagent, 5,5ˈ-dithio-bis-(2-nitrobenzoic acid) (DTNB), to produce 2-nitro-5-thiobenzoate 
(TNB) (Figure 3.2). This can be measured using UV-Visible spectroscopy (UV-Vis) at 
412 nm with a known extinction coefficient of 14250 M-1 cm-1 in phosphate buffer (pH 
7.4, 25 °C) (Figure 3.4).27-28 Removal of aliquots from the enzyme-substrate reaction 
solution at specific time points during the conversion process allows for the data to be used 
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in a Lineweaver-Burk double-reciprocal plot, which in turn is used to extract information 
about the activity of AChE. 
 
 
Figure 3.4: Absorption spectra of 2-nitro-5-thiobenzoate. 
 
3.3.2. Inhibition of Free AChE Using Tac 
 To determine the type of inhibition exhibited by Tac, free AChE (i.e. not attached 
to a particle surface) was exposed to Tac at several concentrations in phosphate buffer. The 
activity of AChE with AtCh in the presence of Tac was determined by Lineweaver-Burk 
plots from UV-Vis (Figure 3.5). The activity of AChE in the absence of Tac was then 
determined in a similar manner; the same amount of AChE (6.8 ng) was used in all 




Figure 3.5: Lineweaver-Burk plots comparing inhibition of free vs. immobilized Tac. 
 
3.3.3. Preparation and Characterization of APMS-(s)-Tac  
 Construction of the inhibitor-tethered scaffold was accomplished as shown in 
Figure 3.6. First, as-prepared APMS (i.e., with surfactant remaining in the pores) was 
reacted with 3-aminopropyltriethyoxysilane (APTES). The surfactant was then extracted 
in a solution of HCl/EtOH, to open the pores of the scaffold. The primary amine was 
reacted with succinic anhydride to produce a carboxylate-terminated surface. Activation of 
the carboxylic acid using N, Nˈ-diisopropylcarbodiimide, followed by the addition of 
HOBt for  generation of an active ester for efficient acylation of amino groups.45 This was 
used to tether Tac to the particle surface at three different concentrations. The resulting 
materials are designated APMS-(s)-Tac (low), -Tac (med), and -Tac (high); having 0.23, 
0.28, and 0.32 mmol tacrine per gram of APMS, respectively.  
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Figure 3.6: Synthesis of APMS-(s)-Tac. 
 
 Thermogravimetric analysis (TGA) and N2 physisorption (Table 3.1) were used 
to characterize the physical properties of the materials at each stage of modification. To 
provide a basis for the calculation of the amount of organic modification of each material, 
a portion of the initial batch of APMS was calcined to completely remove the surfactant. 
This represented the maximum possible porosity of the material. The surface area of the 













APMS (calcined) 385 0.89 11 -- 
APMS-(s)-NH2 (extracted) 270 0.62 11 2.02 
APMS-(s)-NH-COOH 233 0.54 9.1 0.61 
APMS-(s)-Tac-(low) 219 0.52 9.1 0.23 
APMS-(s)-Tac-(med) 210 0.50 9.1 0.28 
APMS-(s)-Tac-(high) 224 0.53 9.1 0.32 
 
 
3.3.4. Inhibition Testing of APMS-(s)-Tac-AChE  
 AChE was stirred with APMS-(s)-Tac (low, med, and high), and the particles 
were washed to ensure removal of unbound AChE. The amount of AChE loaded was 
determined by BCA assay46 that was performed before and after loading. Each APMS-(s)-
Tac-AChE (low, med, high) material loaded different amounts of AChE (3.2, 1.2, 5.0 μg 
AChE/APMS (mg), respectively) so adjustments were made by re-suspending the APMS-
(s)-Tac-AChE in phosphate buffer and adding an aliquot of this suspension to the reaction 
solution so that each reaction sample contained the same amount of AChE (6.8 ng AChE 
total). Inhibition tests were then performed using the Ellman’s method assay described 
above.  
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3.3.5. Loading of Congo Red in APMS-(s)-Tac  
 The loading of Congo Red (CR) within APMS-(s)-Tac (high) varied depending 
on the sample, but a typical loading was 1.3 mM dye/mg particles, resulting in a deep red 
nanoparticle, APMS-CR-(s)-Tac (Figure 3.7). A control experiment was conducted to 
determine the maximum amount of CR that would release without AChE capping the 
pores.  In this experiment, APMS-CR-(s)-Tac was washed six times with phosphate buffer, 
centrifuging and re-suspending in fresh phosphate buffer each time. It was then shaken for 
one hour in phosphate buffer and supernatant measured by UV-Vis to determine the 
amount of CR in solution. This was repeated for a total of five cycles until no further CR 
could be detected by UV-Vis. The particles were now faint pink in color and were dried 
under vacuum and TGA performed. Approximately 1% of CR could not be removed from 
the particles.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
3.3.6. Dye Release from APMS-CR-(s)-Tac-AChE (Single Addition)  
After this experiment, AChE was attached to fully CR-loaded nanoparticles 
through the tacrine inhibitor to form APMS-CR-(s)-Tac-AChE. Experiments were then 
performed to confirm that tacrine was inhibiting AChE through its active site. Prior to the 
addition of AtCh, the particles (4.1 mg APMS-CR-(s)-Tac-AChE in 659 μL phosphate 
buffer) were shaken for 15 minutes, and the supernatant measured to ensure no CR was 
releasing. An aliquot of AtCh was then added, resulting in an AtCh concentration of 1.70 
mM. The concentration of dye in the supernatant was measured every five minutes to track 
the release of CR after detachment of AChE from the nanoparticle surface using UV-Vis 




Figure 3.7: Congo Red release at several concentrations of AtCh. 
 
 This was repeated with three additional concentrations of AtCh (1.27, 0.78 and 
0.36 mM). The release profiles were plotted and fit as pseudo-first order association 
kinetics (Rate = kˈ[A]) to determine the initial release rates and maximum (plateau) amount 
of dye (Table 3.2). Pseudo-first order (A + B  P) has a second order reaction (Rate = 
k[A][B]) where [B] is has a high enough concentration that when the reaction goes to 
completion, the [B] remains constant (independent of [A]), defining it as kˈ = k[B]. For 
these experiments, AtCh has to first displace AChE and then CR must leave the interior of 
the particle. Similar to the pseudo-first order, the initial release of AChE can be defined as 
[B], releasing a set amount of AChE, independent of the amount of CR in the particle. The 
release of CR can be defined as [A], giving a pseudo-first order rate equation. A change of 












1.70 0.063 0.68 
1.27 0.055 0.42 
0.78 0.044 0.32 
0.36 0.033 0.25 
 
 
3.3.7. Dye Release from APMS-CR-(s)-Tac-AChE (Multiple Additions) 
 APMS-CR-(s)-Tac-AChE (high) was prepared and washed as previously 
described. AtCh was then added (0.781 mM in solution) and the concentration of CR in 
the supernatant was measured every five minutes to track the release of CR (Figure 3.8). 
After a plateau was reached (~20 min), an additional aliquot of AtCh (0.781 mM in 
solution) was added. The supernatant continued to be measured until the second plateau 
was reached (~50 min). This process was repeated with a third aliquot of the same 





Figure 3.8: Congo Red release with multiple additions of AtCh (indicated by arrow). 
 
3.3.8. Dye Release from APMS-CR-(s)-Tac-AChE (Recycling)  
 To show the recycling ability of APMS-CR-(s)-Tac-AChE, the material was 
sequentially exposed to AtCh, 0.36 mM total in solution, with several washes with 
phosphate buffer between cycles. This was to ensure that any release of CR or AChE was 
removed before the second cycle (Figure 3.9). The amount of dye released in the second 
test was approximately 56% of the original amount (0.14 vs. 0.25 µM).  
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Figure 3.9: Sequential release of dye from APMS-CR-(s)-Tac-AChE. 
  
3.3.9. Dye Release from APMS-CR-(s)-Tac-AChE (Solution Comparison (AtCh))  
 
 The triggered release system was also tested in protein-containing solutions. 
Attachment of AChE was accomplished using the procedure described above to form 
APMS-CR-(s)-Tac-AChE. Three separate experiments were conducted in phosphate 
buffer, 10 % fetal bovine serum (FBS), and human serum. The particles used in the human 
serum were allowed to reach an equilibrium with any proteins binding to the surface of 
APMS-CR-(s)-TAC-AChE by shaking the particles for 60 minutes in human serum. 
Prolonged shaking to reach equilibrium for the particles in FBS was reduced to 15 minutes 
to reach equilibrium, resulting from the smaller concentration of proteins in solution. A 
single aliquot of AtCh (8.2 mM total in solution) was added and the release of CR tracked 
by UV-Vis (Figure 3.10). The release of CR was measured every five minutes until a 
plateau was reached, and then the experiment was terminated. Addition of the Ellman’s 
reagent to the final supernatant for the phosphate buffer sample and subsequent  
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measurement by UV-Vis ensured that the hydrolysis of AtCh had occurred. The initial 
release rates and maximum release amounts were: phosphate buffer (0.136 mM/min, 1.35 
mM), FBS (0.105 mM/min, 0.96 mM) and human serum (0.074 mM/min, 0.87 mM).  
 
 
Figure 3.10: Dye release comparison in different solutions with set [AtCh]. 
 
3.10. Dye Release from APMS-CR-(s)-Tac-AChE (Solution Comparison (Paraoxon)) 
 Testing the triggered release system in alternative solutions  using paraoxon 
instead of AtCh was performed. Attachment of AChE was accomplished through the 
previously described procedure to form APMS-CR-(s)-Tac-AChE. The same experimental 
procedure as described in section 3.3.9 was followed with each alternative testing solution 
using a single aliquot of paraoxon (8.2 mM total in solution), and the release of CR was 
tracked by UV-Vis (Figure 3.11). The amount of CR released into the solution was 
measured every five minutes until a plateau was reached, and then the experiment was 
terminated. The initial release rates and maximum release amounts were: phosphate buffer  
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(0.455 mM/min, 2.90 mM), FBS (0.246 mM/min, 1.76 mM) and human serum (0.154 
mM/min, 1.67 mM). The supernatant from the phosphate buffer solution was removed and 
AChE actitivty tested to confirm the inhibtion by paraoxon. The Ellman’s method was 
perfromed with the addtion of AtCh (0.69 mM in solution) and DTNB and shaken for 30 
minutes. This resulted with no measurable production of 2-nitro-5-thiobenzoate, 
confirming the inhibition of AChE. For FBS and human serum solutions, the Ellman’s 
method resulted in false positives due to the DTNB reacting with thiol-containing proteins 
present in solution. 
 




3.4.1. Selection of Scaffold  
 The detection system requires the cooperation of several components within close 
proximity of each other to act as a triggered release system.  The use of porous silica allows 
the structural integrity of the detection device to be retained, allowing the scaffold to  
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withstand repeated washing cycles and re-cycling of the material without deteriorating. 
Mesoporous silica offers a way to control important structural characteristics such as 
surface area and pore diameter and allows for a large interior pore volume to retain a dye. 
The surface of mesoporous silica can be readily modified with various functional groups, 
tailoring the material to allow for attachment of the desired inhibitor.  
3.4.2. Selection of Inhibitor  
 The selection of a proper inhibitor relies on several factors, which must be 
considered to allow for the system to function properly. These factors consist of the nature 
of inhibition, ability to immobilize the inhibitor on the scaffold, and nature of inhibition 
after immobilization. With these in mind, the starting point of the selection process was to 
find an inhibitor that was competitive to allow for only a temporary tether of the enzyme 
within the AChE active site. While paraoxon is not the substrate for AChE, paraoxon will 
phosphorylate the active site of AChE, disrupting the inhibitor-enzyme interaction.  
 Reversible inhibition of AChE has been used to treat neurodegenerative disorders 
such as Alzheimer’s disease (AD), which is caused by a reduced number of cholinergic 
neurons and ACh.8, 47 Reversible inhibitors can be separated into two categories dependent 
on their role in substrate conversion. Competitive inhibitors compete with the substrate for 
the active site of the enzyme, whereas non-competitive inhibitors can react with the 
substrate-enzyme complex, binding to a site separate from the active site, decreasing the 
conversion rate to product.48 Examples of both types of inhibitors have been studied to find 
their interaction with the AChE active site and how this determines the nature of their 
inhibition.8 
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 AChE has an elongated pocket in which the catalytic anionic site (CAS) is located 
at the base with an additional peripheral anionic site (PAS) located at the mouth of the 
pocket (Figure 1.11). Both of these sites have shown to play a crucial role in determining 
the type and degree of inhibition. For example, the AChE inhibitor donepezil binds to the 
PAS, resulting in non-competitive inhibition, while tacrine binds to the CAS, resulting in 
competitive inhibition at high concentrations.8, 36-42 It is also possible to block both the PAS 
and CAS with a dual binding inhibitor using a bivalent ligand. The use of two tacrine 
molecules, bound by a polymethylene spacer, made contact with the CAS and PAS (Figure 
3.12).36   
 
 
Figure 3.12: AChE inhibtiors.8, 36-42  
 
For the nanoparticle-based triggered release system, binding of the inhibitor to the 
CAS must occur for competitive inhibition, resulting in the fast release of AChE from the 
surface of the silica. Tacrine has been commonly used as a competitive inhibitor of AChE 
and offers functional groups that can be used to tether the inhibitor to the surface. 8, 36-42 
Immobilizing AChE allows the pores of the scaffold to be capped, retaining the loaded dye 
and acting as the triggered release system. The attachment of tacrine can be accomplished 
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through a peptide bond with the available primary amine on the center ring (Figure 3.6).  
 To ensure interaction with the CAS, the chain length from the silica surface to the 
end of the inhibitor must be at least 14 Å to reach within the deep pocket of the AChE 
active site.36 Without this minimum chain length, interaction with the PAS could result, 
leading to non-competitive inhibition. In our case, after the peptide bond formation, the 
chain length could be estimated to be around 19 Å using average bond lengths for C-C (154 
pm) and C-N (147 pm) bonds molecular modeling would be needed for maximum 
accuracy.49  
3.4.3. Type of Inhibition  
 The last point to address was whether tacrine maintained its role as a competitive 
inhibitor after immobilization. Enzyme inhibition can be determined through a variety of 
methods by comparing the activity of the free enzyme with and without the inhibitor. A 
Lineweaver-Burk plot is a useful tool to study enzymatic inhibition, because the effects of 
competitive and non-competitive inhibition produce graphically distinct results that are 
easily observed. In competitive inhibition, the y intercept (1/Vmax) remains the same in the 
presence of the inhibitor and the x intercept (-1/KM) decreases. This is a result of the 
observed binding constant of the substrate changing in the presence of a competitive 
inhibitor, although at sufficiently high concentrations of substrate the maximum velocity 
of the reaction remains the same. The new x intercept, -1/(1+[I]KI), where [I] = the 
concentration of inhibitor and KI is the dissociation constant of the inhibitor with respect 
to the enzyme, is sensitive to the concentration of inhibitor.48 The comparison of AChE 
activity with and without tacrine are shown in Figure 3.5. The y intercept of all plots were  
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identical, and the x intercepts of each plot decreased as the concentration of tacrine 
increased. Lower concentrations of tacrine were tested but resulted in non-competitive 
inhibition, as previously found in literature.41, 50-52 To ensure competitive inhibition, a 
higher ratio of inhibitor to AChE was maintained. Confirmation of competitive inhibition 
of tacrine free in solution under the set conditions allowed for a standard to which the 
immobilized inhibitor could be compared.  
3.4.4. Synthesis of APMS-(s)-Tac  
 The design of the scaffold and its functionalization, as previously discussed, 
played an important role in trying to maintain the competitive inhibition of tacrine with 
AChE. Calcined APMS was first characterized to ensure that the starting material was 
adequate to not only allow for addition of the organic moieties but also to allow for loading 
of dye (Table 3.1). A large pore diameter (~1 nm) and large pore volume for the final 
functionalized material were both desired. This results in easier loading and release of dye 
from the interior pore volume. The large pore volume allowed the amount of dye that would 
release once AChE was displaced to be maximized. Analysis of the pore volume (0.89 
cm3/g) of a material with this surface area and pore diameter suggested a porous material 
with highly interconnected pore structure, consistent with previous publications on 
APMS.6, 53 A pore volume of this size was suitable to continue with surface modification. 
 Next, the surface functionalization steps to add the inhibitor to APMS were 
performed (Figure 3.6). The first synthetic step was the attachment of the primary amine 
to the surface. Limiting the aminosilane functionalization primarily to the external particle 
surface was controlled by using as-prepared APMS, in which the surfactant was still intact,  
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preventing modification of the pore surfaces. AChE was required to be on the surface not 
only to block the pores, but also to allow the substrate easier access to the CAS. Removal 
of the surfactant following functionalization with the primary amine, confirming that 
modification hard primarily taken place on the external surface. A short functionalization 
time also helped to control the location of the amine, although some diffusion of APTES 
within the surfactant micelles is expected.54 
 Thorough population of the surface with the amine (2.02 mmol/g) allowed the 
carboxylic acid functionality to be added. The extent of modification with succinic 
anhydride was less than with the amine addition (0.61 mmol/g versus 2.02 mmol/g) 
resulting with some unreacted amine groups, which was expected. The last 
functionalization step was the controlled addition of tacrine to the surface at several 
concentrations by adjusting the amount of tacrine available during the peptide coupling 
(Table 3.1). The coupling procedure begins with the activation of the carboxylic acid with 
the introduction of the diisopropylcarbodiimide to form the highly reactive o-acyl-urea. To 
prevent racemization, HOBt reacts with the o-acyl-urea to form an active ester. 
Introduction of tacrine at set concentrations limits the amount that can be immobilized 
through the peptide bond formation.45 The resulting mixed surface of unreacted amines, 
carboxylic acid groups, and tacrine did not appear to influence inhibition testing with 
AChE (Figure 3.13). Porosity was retained throughout the modification process, 
determined by analysis of the SABET, Vpore, and dpore after each step (Table 3.1). A decrease 
in each of these physical parameters is typical of functionalization in which small amounts 
of silane may modify the mouths of the pore. Increasing the length of the linker to the  
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tacrine would decrease the porosity even further. Despite the decrease, the final porosity 
and pore volume was sufficient to retain the dye and allow for the capping by AChE.  
 
 
Figure 3.13: Conceptual influences on surface functionalization and AChE loading and CR releasing. 
 
3.4.5. Immobilization of AChE  
 The immobilization of AChE onto the surface of APMS-(s)-Tac was controlled 
by many factors resulting from the physical characteristics of AChE in relation to the 
surface functionalization of APMS. For example, a comparison of the amount of AChE 
loaded to the amount of tacrine that was present on the surface showed that excess tacrine 
was always present. For example, even at the lowest immobilized tacrine concentration, 
APMS-(s)-Tac (low) had approximately 0.014 mM tacrine per mM AChE. Comparison of 
these concentrations showed that the packing of AChE on the surface was not limited by  
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the number of available tacrine molecules. This would result in a surface that had not only 
unreacted amine and carboxylic acid groups but free tacrine (Figure 3.13 A). The high 
ratio of tacrine to AChE could result from the relative size of AChE (9.3 nm x 8.1 nm x 
9.7 nm).55 If two or more inhibitor molecules were less than 81 Å apart, then AChE would 
bind to one of them and cover the others. The benefit of having an excess of available 
inhibitor was to increase the likelihood of tight packing on the surface, allowing the pores 
to be capped most effectively. The large size of AChE in comparison to the average pore 
diameter (~ 9.1 nm) also resulted in the possibility that only one AChE would be needed 
to cover a pore (Figure 3.13 C). Two or more AChE could also cover a pore (Figure 3.13 
B); the difference between these two scenarios was controlled by the distance between 
pores and the density of AChE packing on the surface. The ability for a single or multiple 
AChE to cap a pore further increases the potential for retaining the dye.  
3.4.6. Inhibition Testing of APMS-(s)-Tac-AChE  
 For the triggered release system to be functional, the immobilized tacrine had to 
continue to perform as a competitive inhibitor. As in the case of free tacrine and AChE, 
APMS-(s)-Tac-AChE kinetics were evaluated using a Lineweaver-Burk plot (Figure 3.5). 
Intersection of the three APMS-(s)-Tac-AChE samples at the same point on the y-axis 
found with and without tacrine confirms that tacrine is still a competitive inhibitor after 
immobilization. The concentration of immobilized tacrine was calculated based on the 
amount of AChE needed (6.8 ng per sample) for each of the sample. The concentrations of 
tacrine do not directly correspond to the slopes of the lines such that the higher the 
concentration of inhibitor, the steeper the slope. This resulted from the variation in AChE  
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Loaded, 3.2, 1.2, 5.0 μg AChE/APMS (mg) for each of the materials, APMS-(s)-Tac (low, 
med, high), respectively. However, the slope increase corresponded directly to the starting 
material concentration of immobilized inhibitor, from 0.23 to 0.32 mmol/g APMS. The 
larger slope using immobilized AChE compared to free AChE can be attributed to a higher 
localized concentration of tacrine on the surface compared to free in solution.56 This helped 
to ensure the ratio of tacrine to AChE was large enough to force competitive inhibition 
over non-competitive inhibition. In terms of a triggered release system, the large slope 
indicates that the system is effective at very low concentrations of substrate and is sensitive 
to small changes in substrate concentrations. 
3.4.7. Dye Selection  
 Congo Red (CR) (pKa = 4.1, Figure 3.14) was selected as the dye in this system 
because it could be loaded in significant amounts at pH = 2.3, above the isoelectric point 
(IEP = ~ pH = 2) of SiO2. The majority of the surface of silica nanoparticles at all pHs 
contains ≡Si-O-Si≡ and ≡Si-OH. At a pH below the IEP of silica, the surface has an overall 
positive charge, with the surface containing protonated silanols (≡Si-OH2+) where it will 
remain mainly deprotonated. At a pH above the IEP of silica, the surface has an overall 
negative charge, with the surface containing deprotonated silanols (≡Si-O-).57 This allowed 
for weak interaction with the anionic surface of APMS. During the release experiments, 
the use of a basic buffer (phosphate buffer, pH = 7.3) results in a deprotonation of the 
surface silanols and the surface of APMS will have a negative  potential.53 This change 
in buffer results in the deprotonation of CR, repelling it from the pore surface and releasing 
the dye. Although the pore capping step was performed above pH = 4.1, the interaction of  
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AChE with the surface bound tacrine occurred with sufficient speed that the majority of 
the dye remained within the pores. In control experiments, it was found that the only about 
1% of the loaded CR remained within the particles. APMS has a highly inter-connected 
pore structure, which allows dye to be loaded deep within the nanoparticles. The native 
and modified material may have pockets of different surface charge that could also trap 
CR. Despite this, the majority of dye could be released to give direct visual indication of 
the AChE reaction. 
 
 
Figure 3.14: Structure and color of protonated and deprotonated forms of Congo Red  
 
3.4.8. Release of CR from APMS-CR-(s)-Tac-AChE 
The release of CR using a single aliquot of AtCh at several concentrations allowed a release 
profile to be constructed under ideal conditions. Quantification of CR release provided 
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Figure 3.15: Michaelis-Menten kinetics of CR release. 
 
If the rate of dye release is sufficiently rapid, it should reflect enzymatic kinetics, 
following a Michaelis-Menten model.48 Indeed, plotting the rate of CR release versus 
substrate concentration showed a graph typical of Michaelis-Menten kinetics (Figure 
3.15). This implies that as the substrate concentration increases, the rate of CR release will 
also increase until the point of saturation by the substrate. This confirms that the process 
of dye release and the process of substrate recognition are independent of each other. 
Calculation of kinetic constants from this plot gave kcat/Km = 3.73 x 10
4 M-1s-1, which is 
comparable to the actual value of 2.72 x 102 M-1s-1 measured by Ellman's method.  
Figure 3.8 shows that it was possible to release more CR after the first addition 
(0.78 mM in solution) of AtCh by adding more AtCh after the rate of CR had plateaued.  
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However, the amount of CR release is substantially lower, because free AChE 
now competes for the AtCh with bound AChE. After the first plateau, an additional aliquot 
(0.78 mM in solution) of AtCh showed an increase of CR until a second plateau within a 
similar 20-minute window and a measurable signal within five minutes. Repeating this a 
third time (0.78 mM in solution) resulted in a similar result. After this point, additional 
aliquots did not give an increased CR signal. The large amount of free AChE was 
hydrolyzing the substrate faster than the amount of time it took AtCh to reach the bound 
AChE.  
 On the other hand, isolation and resuspension of the particles between the first 
and second additions of AtCh should eliminate cross-reaction with free AChE. This was 
indeed the case for the second cycle with a slightly lower maximum release amount 
(Figure 3.9). The smaller amount of CR released was consistent with a smaller amount of 
AChE on the surface and a smaller amount of CR still remaining in the material. These two 
different experiments (sequential addition and recycling) showed that the material retained 
its structural integrity after multiple substrate additions and can be washed and recycled 
for further use. 
 Extensive testing of the triggered release system using AtCh showed the stability 
of the inhibitor-enzyme interaction. To use this triggered-release system as a detection 
system for organophosphates, the same must hold true. In the presence of an 
organophosphate, such as paraoxon, a serine residue within the active site of AChE is 
phosphorylated.58 The interaction of tacrine with the active site of AChE should therefore 
be disrupted by the introduction of paraoxon, causing the release of AChE from the surface 
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of APMS-(s)-Tac-AChE. The release of CR from the interior pore volume could then be 
tracked in similar fashion as with AtCh.  
CR release kinetics could be used to compare the sensitivity of the AChE release 
in the presence of AtCh versus paraoxon. The initial release rate and maximum release of 
CR in phosphate buffer with AtCh (Figure 3.10; 0.136 mM/min and 1.35 mM) compared 
to the addition of paraoxon (Figure 3.11; 0.455 mM/min and 2.9 mM) was attributed to 
difference in the mechanism of AChE release. The hydrolysis of AtCh by AChE (1.6 x 104 
M-1min-1) was lower than the inhibition of AChE with paraoxon (2.9 x 105 M-1min-1).59 
This results in a faster rate of release of AChE from the surface and a larger release of CR 
with the inhibition of AChE. The release of CR using paraoxon confirms the ability of this 
system to work not only with a substrate but with an organophosphate to allow for direct 
detection. 
3.4.9. Selectivity of Trigger  
 In phosphate buffer, the triggered release system worked effectively to release 
CR. Moving away from this controlled environment to a solution containing other 
molecules and proteins allowed for the selectivity of the trigger to be tested. Cell culture 
media, 10% FBS, contained a small amount of proteins and other growth factors60 that 
could potentially interfere with substrate selectivity or release of AChE. 
  Simple exposure of APMS-CR-(s)-Tac-AChE to 10% FBS showed no release of 
CR. This showed that the presence of other molecules did not interfere with the 
immobilization of AChE with tacrine. The release of CR from APMS-CR-(s)-Tac-AChE 
did not occur until after the addition of AtCh (Figure 3.10) or paraoxon (Figure 3.11). The  
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release of CR using either of the substrates resulted in a slightly decreased initial release 
rate and maximum release amount than under the ideal conditions using only phosphate 
buffer. The lower rates were expected due to the interference with other proteins within the 
reaction mixture that will limit the diffusion rate as well as possible interactions with the 
substrate. In the case of paraoxon, phosphorylation of other proteins can occur, decreasing 
the actual amount of paraoxon reaching the particles. To ensure that the release of CR was 
due to the addition of substrate, in the case of AtCh, addition of Ellman’s reagent to the 
supernatant showed hydrolysis of AtCh. This shows that not only was the system able to 
release AChE in a complex mixture of other proteins, but specifically releases it when the 
substrate is present. 
 Taking the selectivity of this system a step further and increasing the potential for 
premature triggered release, a similar experiment was performed but using 100 % human 
serum. The use of 100% serum increases the concentration of proteins to 4.0-9.0 g/dl. With 
a larger number of proteins in solution, an equilibrium with any binding proteins was 
allowed to be reached. This ensured that competition between substrate and binding 
proteins did not occur when forming the corona, a layer of proteins electrostatically bound 
to the surface of the particle.61 Despite the large increase in concentration of free proteins 
and bound proteins, the system still showed CR after the addition of AtCh (Figure 3.10) 
or paraoxon (Figure 3.11). The rates of release and overall maximum release amount were 
slightly higher than FBS but remained less than with the ideal conditions. The lower release 
of CR in FBS was attributed to the lower amount of CR loaded in the sample (0.65 mM 
dye/mg particles) compared to testing in human serum and phosphate buffer (0.86 mM/mg  
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particles). The ability of this system to release CR within a system flooded with other 
proteins shows the selectivity that is afforded through an enzyme-inhibitor pair and creates 
an effective detection system. 
 
3.5. Conclusions 
 The need for an efficient and easily accessible detection system for 
 organophosphorus compounds have expanded this area of research into the need for a  
system in which no additional external influence is needed other than the neurotoxin itself. 
The use of mesoporous silica nanoparticles offers a unique scaffold in which the entire 
detection system can be retained. In this system, the exterior modification using an inhibitor 
allows an enzyme-inhibitor pairing to act as the trigger and cap of the material. The loading 
of the interior pore volume with a dye is held intact by the cap and its release was the direct 
result of the triggered release of the enzyme. 
 In the detection system described here, the exterior of APMS was functionalized 
with the competitive inhibitor (tacrine) that was confirmed both free in solution and when 
immobilized. This was followed by loading the interior pore volume with CR and 
subsequent inhibition of AChE to tether it to the surface. AChE remained inhibited until 
the addition of substrate or organophosphorus compound. Addition of either of these 
substrates prompted the displacement of AChE and allowed for the release of CR. This 
could be tracked visually and quantified easily by UV-Vis. The specificity of the triggered 
release system was tested in systems that reflected cell culture media and in full HS. 
Despite the abundance of proteins contained within these solutions, AChE remained intact  
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and only the addition of AtCh or paraoxon caused the release of CR. 
 The design of the detection system is highly advantageous due to the high degree 
of specificity. Utilizing the enzyme-inhibitor pair for the triggered release system removes 
the need for an additional influence, chemical or physical, to give a visual response. This 
shows promise under biological conditions in which the addition of chemical or other 
external triggers can be detrimental to the system. A self-contained system with direct 
detection circumvents this problem. Additionally, this system helps eliminate false 
positives and gives a fast visual indication that can be seen by the naked eye, allowing for 
use by an untrained individual. The use of the enzyme-inhibitor triggered release system 
has shown promise within the field of triggered response systems with minimal time to 
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 Nerve agent detection methods have continually evolved to help limit the 
exposure of military and civilian personnel to these potentially deadly organophosphorus 
compounds. Optical biosensors, particularly those based on colorimetric1-3 assays, have 
several benefits including increased portability and real-time detection.4-15  Many of these 
assays are inhibition-based detection systems measuring the change in activity of 
acetylcholinesterase (AChE).15-20 The rationale for the use of AChE as the basis for these 
biosensors lies with its interaction with organophosphates, resulting in the phosphorylation 
of the AChE active site. The hydrolysis rate of acetylcholine by AChE can then be 
measured before and after exposure to an organophosphate, and the kinetics determined.  
Recently, the development of two direct response systems; one for detection and 
decontamination using organophosphorus hydrolase (OPH) and the other using AChE for 
increased sensitivity for detection were developed by our group. The use of a porous silica 
support allowed a competitive inhibitor of each enzyme to be attached to the nanoparticle 
surface, temporarily tethering the enzyme to the surface. This allowed the enzyme to block 
the pores of the silica, acting as a triggered release mechanism when in the presence of a 
substrate. In the case of AChE, organophosphates can also release the enzyme by 
permanently modify its active site. If the interior pore volume of the silica is loaded with a 
dye, the release of the enzyme caused release of the dye, which could be visually tracked  
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with the naked eye, allowing for use by an untrained individual without complex 
instrumentation and quantified by UV-Visible spectroscopy. The use of an enzyme-
inhibitor trigger allowed for high specificity of the system, in which release of the enzyme 
occurred only in the presence of the substrate or organophosphate, for the AChE based 
system (Figure 4.1).  
 
 




The initial purpose in designing these detection systems was to combine fast 
detection with limited false positives, regardless of the specific organophosphate detected. 
While the detection system using AChE does show a fast response, further experiments 
were required to determine and compare the rates of release using different 
organophosphates. Using the same mesoporous silica scaffold and competitive tacrine 
inhibitor-AChE pair, described in Chapter 3, several organophosphates were tested and the  
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kinetics of dye release compared to the rate of AChE phosphorylation.  
4.2. Experimental Section 
 
4.2.1. Materials and Instrumentation 
  See All materials were purchased from Sigma-Aldrich, VWR and Life 
Technologies. UV/Vis spectra were measured using a Perkin-Elmer Lambda 35 
spectrophotometer system. Thermogravimetric analysis (TGA) was performed on a 
PerkinElmer Pyris 1 DSC-TGA. Scans were performed under a mixed flow of nitrogen 
(85%) and oxygen (15%) between 25 °C and 800 °C at 20 °C/min with a thermal hold at 
100°C for 15 minutes to remove any residual water. N2 adsorption and desorption 
isotherms were obtained on a Micromeritics TriStar instrument. Surface areas were 
measured using the Brunauer-Emmett-Teller (BET) method and pore size distributions 
were calculated from a modified Kruk, Jaronic and Sayari (KJS) method using the 
adsorption branch. 
4.2.2. Synthesis, Functionalization and Characterization of APMS 
4.2.2.1. Synthesis of Acid-Prepared Mesoporous Silica (APMS)  
 APMS was synthesized as previously described.21-22 
4.2.2.2. Synthesis of APMS-(s)-NH2  
 Pore-blocked APMS (1.8 g) was suspended in hexanes (400 mL) to which 3-
aminoproplytriethoxysilane (APTES) (1.8 mL) was added. The solution was refluxed for 
3.5 hours under an inert atmosphere (N2) to form the product APMS-(s)-NH2. To remove 
surfactant from the pores, APMS-(s)-NH2 was extracted by refluxing with acidified ethanol  
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(0.1 M HCl in ethanol) for 24 hours (3X), filtering and letting dry between each cycle. The 
degree of modification was characterized by thermogravimetric analysis (2.02 mmol 
modification/g APMS) and the physical properties characterized by nitrogen physisorption. 
The resulting APMS was then placed under vacuum to keep dry until further modification. 
4.2.2.3. Synthesis of APMS-(s)-NH-COOH  
 Extracted APMS-(s)-NH2 (1.5 g) was suspended in acetonitrile (dry) under an 
inert atmosphere (N2) to which triethylamine (950 µL) and succinic anhydride (355 mg) 
was added. The solution was stirred at 60°C for 21.5 hours then collected by vacuum 
filtration. Several washings with trifluoroacetic acid (0.1% in water) and acetonitrile were 
followed by drying overnight. The degree of modification was characterized by 
thermogravimetric analysis (0.61 mmol modification/g APMS) and the physical properties 
characterized by nitrogen physisorption. The resulting APMS-(s)-NH-COOH was then 
placed under vacuum to keep dry until further modification. 
4.2.2.4. Synthesis of APMS-(s)-Tac 
 In a typical synthesis, APMS-(s)-NH-COOH (57 mg) was suspended in 8 mL 
dimethylformamide (DMF) to which, hydroxybenzotriazole (HOBt) (82 mg), N, N’-
diisopropylcarbodiimide (90 mg) and 4-dimethylaminopyridine (DMAP) (4 mg) were 
added and stirred for 1 hour. Tacrine hydrochloride (Tac) (14 mg) was then added and 
stirred for 19 hours. The particles were collected by vacuum filtration and washed with 
DMF then MeOH and left to dry overnight. The degree of modification (0.28 mmol 
modification/g APMS) was determined by thermogravimetric analysis and the physical 
properties characterized by nitrogen physisorption. The resulting APMS-(s)-Tac was then  
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placed under vacuum to keep dry until further modification. 
4.2.3. Congo Red Loading and Release Using APMS-CR-(s)-Tac-AChE 
4.2.3.1. Loading of Congo Red (APMS-CR-(s)-Tac)  
 In a typical loading procedure, Congo Red (CR) (40 mg) was added to a citrate 
buffer (5 mL, 0.01 M, pH 3.98) to make a CR stock. APMS-(s)-Tac (4.0 mg) was shaken 
(24 hr) with the CR stock (3 mL, 11.5 mM). The sample was centrifuged and the 
supernatant measured by UV-Vis to determine the amount of CR loaded. The material was 
washed once with citrate buffer and phosphate buffer (100 mM, pH = 7.3) to prepare for 
loading with AChE. 
4.2.3.2. Determination of [AChE] 
 Free AChE concentrations and AChE immobilized onto APMS-(s)-Tac were 
calculated using a PierceTM BCA protein assay kit using a standard bovine serum albumin 
(BSA) calibration curve.23 Triplicate samples measured for the standard curve. 
4.2.3.3. Loading AChE (APMS-CR-(s)-Tac-AChE)  
 A typical loading required 4.0 mg APMS-CR-(s)-Tac suspended in a stock AChE 
solution (508 µg/mL in phosphate buffer (100 mM, pH = 7.3)) and placed on a rotating 
platform for 24 hours. The sample was centrifuged, supernatant removed and immobilized 
AChE determined by the BCA assay. The particles were washed with phosphate buffer 
until all non-encapsulated CR was removed.  The particles were then re-suspended in the 
appropriate amount of phosphate buffer for kinetics testing. 
4.2.3.4. Release of Congo Red from APMS-CR-(s)-Tac-AChE 
In a typical reaction, APMS-CR-(s)-Tac-AChE (0.11 mg AChE total, 0.608 µM)  
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was suspended in phosphate buffer (629.18 µL, 100 mM, pH = 7.3). The sample was 
shaken for 15 minutes, centrifuged and supernatant measure to show no CR releasing. An 
aliquot of paraoxon was then added to give the desired concentration in solution (5.06, 7.08 
or 8.23 mM). The sample was shaken for a set time interval (2.5 - 5 min) and the reaction 
stopped by centrifugation. The supernatant was then measured by UV-Vis to measure the 
amount of CR released based on a calibration curve. This procedure was repeated with 
additional organophosphates (parathion, demeton-s and malathion), adjusting the 
experimental conditions for the desired concentrations in solution. 
4.2.3.5. Inhibition of AChE After Release from APMS-(s)-Tac-AChE 
 After release of CR from APMS-CR-(s)-Tac-AChE using demeton-s, the sample 
was centrifuged and the supernatant removed. To the supernatant (200 µL), Ellman’s 
reagent, 5, 5’-dithio-bis-(2-nitrobenzoic acid) (20 µL) and acetylthiocholine (AtCh) (2 µL) 
from an AtCh stock (7.64 mM) was added. The reaction was allowed to react for 25 min 
and measured by UV-Vis. This was compared to a background standard sample of the same 
concentrations but without AChE and measured by UV-Vis. 
 
4.3. Results  
4.3.1. Preparation and Characterization of APMS-(s)-Tac  
Synthesis and characterization was the same as described in Chapter 3. The material 
designated APMS-(s)-Tac (med), was used that had 0.28 mmol tacrine per gram of APMS.  
4.3.2. Release of CR from APMS-CR-(s)-Tac-AChE 
 The loading of CR and attachment of AChE was the same as described in Chapter  
  
 123 
3. Experiments were then performed to compare the rates of release using different 
organophosphates. Prior to organophosphate addition, the particles were shaken for 15 
minutes in phosphate buffer and the supernatant measured to ensure no CR was releasing.  
An aliquot of organophosphate (paraoxon, parathion, demeton-s or malathion) was then 
added, resulting in the desired concentration in solution (5.06, 7.08 and 8.23 mM). The 
concentration of CR in the supernatant was measured after a set time interval of five 
minutes to track the release of CR after detachment of AChE from the nanoparticle surface. 
Varying the concentration of organophosphate and measuring the release of CR within a 
set time period allowed for the plotting of this data in a Lineweaver-Burk plot to calculate 
the release kinetics (Table 4.1) before the CR release plateau. 
 
Table 4.1: CR release kinetics with different organophosphates.24-25 










Paraoxon 1 2.96 x 10-6 1.21 x 10-6 4.87 403 
Parathion 35 1.88 x 10-6 1.92 x 10-6 3.09 160 
Demeton-S 55 1.84 x 10-6 2.28 x 10-6 3.03 133 






4.4.1. Mechanism of Phosphorylation  
 Previous testing of the detection system with AtCh and paraoxon showed its high 
specificity for these compounds. At this point, we were interested in exploring the ability 
of this detection system to detect and decontaminate other, related organophosphates. 
Differences among the organophosphates were controlled by the rate of phosphorylation 
within the AChE active site.  Increased toxicity results in increasing rates of AChE 
phosphorylation, inhibiting the activity of AChE.26-27 
 
 
Figure 4.2: Hydrolysis of acetylcholine within the AChE active site.26 
 
The AChE active site consists of a catalytic triad of serine (S), glutamic acid (E)  
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and histidine (H) (Figure 4.2).26 The negatively charged glutamic acid interacts with the 
positively charged nitrogen on ACh to stabilize ACh within the active site. The serine 
hydroxyl is acetylated by ACh with the assistance of the nearby histidine, leading to the 
release of choline. This is followed by a nucleophilic attack by a water molecule, causing 
deacetylation and regenerating the enzyme. In the poisoning of AChE by 
organophosphates, a similar process is followed by the rate of deacetylation is exceedingly 
slow, varying depending on the substituents on the phosphorus atom. Thus, AChE cannot 
function and a buildup of ACh occurs (Figure 4.3).26  
 
 
Figure 4.3: Phosphorylation of the AChE active site.26 
 
Inhibition of AChE by organophosphorus compounds has been characterized by 
the inhibition constant, ki. This constant is comprised of two factors that control the overall 
rate of inhibition. The first is the dissociation constant (Kd) that is determined by the affinity 
of the organophosphate for the serine residue. The formation of the organophosphate-
enzyme intermediate relies heavily on the reactivity of the phosphorus ester and steric 
constraints of the organophosphate. The second determining factor is based on the rate of 
formation of the organophosphorus ester (kp), which has been shown to be controlled by  
  
 126 
the leaving group (X). Overall, these two rates determine the inhibition constant 
(ki) for a particular organophosphate which is equal to kp/Kd.
27-28 This provides a basis to 
compare the rates at which organophosphates inhibit AChE.  
4.4.2. Organophosphate Surrogates 
 Due to the extreme toxicity of organophosphate nerve agents, chemical surrogates 
with similar structures are often used in a laboratory setting. These surrogates are usually 
commercially available pesticides (Figure 4.4).26, 29 (these are not three dimensional at the 
phosphorus center) Testing of the proposed detection system used surrogate species that 
contained similar structure characteristics to both G and V-agents. In general, G-agents 
contain a halide leaving group bound to the phosphorous (P-X) such as with sarin and V-
agents contain a sulfur-containing leaving group (P-S) such as with VX.27  
 
 





Altering the rate of phosphorylation has been a commonly pursued strategy in the 
development of pesticides, giving a large library of surrogates to select from. The 
surrogates selected (paraoxon, parathion, demeton-s, and malathion) were chosen to 
represent a range of organophosphate structures. In particular, paraoxon and parathion were 
used as G-agent surrogates, and demeton-s and malathion were selected as V-agent 
surrogates.  
One difference among these surrogates is the replacement of the P=O bond for a 
P=S bond. This has shown to decrease the rate of phosphorylation due to the decreased 
polarizability of the P=S bond. The electropositive character of the phosphorus atom that 
is created by the P=O bond facilitates nucleophilic attack by the serine at the active site of 
AChE. With this in mind, the rates of inhibition (ki) for free AChE have been previously 
determined for several organophosphates such as paraoxon (2.9 x 105 M-1 min-1) and 
demeton-s (1.0 x 103 M-1 min-1) for specific AChE sources such as an electric eel, used in 
this work.28 These values are representative of the inhibition rate of AChE in which half of 
the concentration of enzyme has been inhibited. This would allow for a comparison of each 
of the selected surrogates species by the rates of AChE inhibition. With higher ki values, 
the faster AChE will be released from the surface due to disruption of the inhibitor in the 
enzyme active site and the opposite with smaller ki values. This can be used to track the 
sensitivity of the system with decreasing rates of inhibition from paraoxon to parathion to 
demeton-s to malathion.27 For direct comparison between all surrogates, the use of LD50 
was used. This value represents the dose at which half of the population does not survive. 
The LD50 for the mouse model (oral) was found to be 1, 35, 55, and 1330 mg/m
3 for  
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paraoxon, parathion, demeton-s, and malathion, respectively (Table 4.1).24-25  
4.4.3. CR Release Kinetics 
Disruption of the interaction between the competitive inhibitor tacrine (Tac) and 
the active site of AChE can be caused by the substrate or organophosphate through two 
different mechanisms. Competition between Tac and the substrate for the active site causes 
the release of AChE from the scaffold, opening the pores and allowing CR to escape. The 
AChE is now free to hydrolyze AtCh into product. The rate at which this occurs is 
dependent on the substrate concentration. In the case of organophosphates, the 
phosphorylation of the serine residue disrupts the interaction between Tac and AChE, 
resulting in the uncapping of the pores and release of CR. AChE is now free but inactive 
due to phosphorylation of the active site. The rate at which this response occurs is 
dependent on the rate at which AChE is phosphorylated, (ki) determined by the fitment of 
the organophosphate within the active and the reactivity of the organophosphorus ester.24 
With the current detection system, the kinetics of CR release are related to the rate 
at which AChE is released from the surface, which are in turn related to the rate of AChE 
inhibition. Our expectation was therefore the rate of CR release should be highest for 
paraoxon and lowest for malathion, based on their LD50 values (Table 4.1).
24-25 
Importantly, the AChE should also continue to be inhibited after release from the surface, 
allowing successive cycles of CR release to occur upon repeated exposures to 
organophosphorus compounds. To ensure that inhibition of the released AChE was 
occurring, post-CR release, the activity of AChE was tested using the Ellman’s method30-
31 and confirmed inhibition with the lack of 2-nitro-5-thiobenzoate production. Because of 
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these connections, the Michaelis-Menten kinetics model32 can be used to provide an 
indirect assessment of organophosphorus inhibition of AChE.  
 Measurement of activity was determined by measuring the amount of CR released 
within a time period after the addition of an aliquot of surrogate. This was then repeated 
with several additional concentrations of the surrogate and measuring the amount of CR 
released.  For each surrogate, the rate of CR release compared to surrogate concentration 
was used to create a Lineweaver-Burk plot to determine the release kinetics. CR release 
was determined for each of the preselected surrogates and compared (Table 4.1). Using 
the information calculated, several characteristics about the detection system can be 
determined. 
 The maximum velocity (Vmax) for each of surrogates represents the maximum 
release rate of CR from APMS-CR-(s)-Tac-AChE. This is directly related to the rate at 
which AChE is released from the surface due to phosphorylation. From paraoxon to 
malathion, the Vmax correlates with the decrease in phosphorylation rate of each surrogates 
with the largest velocity reaching 2.96 x 10-6 M/min for paraoxon (Table 4.1). The Vmax 
for parathion and demeton-s are similar with parathion having a slightly elevated velocity. 
The similarity in rates can be attributed to a balance between the decreased polarizability 
of having a P=S (parathion) versus a slower leaving group (demeton-s) both factors 
resulting in changes to the rate of phosphorylation.27 Despite this, differentiation between 
the surrogates was attainable and this differentiation was held constant throughout the rest 
of the kinetic factor comparisons. 
 Typically, the Km is a measure of how much substrate is needed to reach Vmax/2.  
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The smaller the Km, the less substrate that is needed to reach half of the maximum velocity. 
This is controlled by the affinity the enzyme has for its substrate. The higher the affinity, 
the faster substrate is converted to product. In the case of the current detection system, the 
Km represents the same situation but is the affinity the substrate has for the enzyme. 
Increased rates of phosphorylation are a direct result of the organophosphate reacting faster 
with the enzyme, giving smaller Km values and the Km increasing with the decrease in 
phosphorylation rates. This correlates directly with the CR release data (Table 4.1) in 
which the Km values increase from paraoxon (1.21 x 10
-2 M) to the largest for malathion 
(2.55 x 10-2 M). 
 The kcat can be defined as the turn over number of an enzyme, representing the 
number of substrate molecules that are converted to product per enzyme. The higher the 
kcat, the more active the enzyme in substrate conversion. The measurement of kcat for the 
triggered release system is based on the rate at which CR is released. This is controlled by 
the displacement of AChE due to phosphorylation. The faster this process occurs results in 
a higher kcat and is directly proportional to the rate of phosphorylation. This was seen with 
an increase in the kcat of CR release from malathion to paraoxon (Table 4.1). 
While the Vmax, Km, and kcat each define different aspects of the kinetics for an 
enzyme and its substrate, variability in solvents and total enzyme concentration can hinder 
comparisons between different enzymes. Commonly, the use of catalytic efficiency 
(kcat/Km) defines the overall ability of an enzyme to convert substrate to product. While 
experimental conditions and enzyme concentration remained the same, variability between 
each of the surrogate species represents a wide range of structural and electronic  
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differences that all influence the rate of phosphorylation. The use of kcat/Km for comparison 
to the surrogates and the ability to discern between them. This results in the catalytic 
efficiency of the system to be higher for stronger phosphorylating surrogates, i.e. larger kcat 
and smaller Km. The kcat/Km for paraoxon compared to malathion represents the ability for 
the detection system to differentiate between organophosphates by having a 16-fold 
difference in catalytic efficiency for CR released between these two surrogates (403 M-
1min-1 versus 25 M-1min-1). Comparison of paraoxon catalytic efficiency to demeton-s (3-
fold) and parathion (2.5-fold) represents the sensitivity of the system by allowing for 
differentiation based on the amount of CR released.  
 
4.5. Conclusion 
 The ability for organophosphate detection systems to work fast and efficiently 
decreases the probability for a civilian or military personnel to be exposed. This requires 
ease of use of the system while limiting false positives. Using a direct response system that 
is triggered directly by the organophosphate allows for a faster response time to determine 
the threat of exposure faster and the appropriate next step to be taken. Using a mesoporous 
silica scaffold, the proposed detection system uses the interior pore volume to hold a dye 
and its release controlled by an enzyme-inhibitor pair trigger that responded distinctly to 
different organophosphates. 
 The exterior modification of the scaffold, APMS, with the competitive inhibitor 
tacrine was used to tether ACHE to the scaffold after loading the interior pore volume with 
CR. AChE capped the pore of APMS and remained there until the presence of an  
  
 132 
organophosphate surrogate. Phosphorylation of AChE disrupted the enzyme-inhibitor 
interaction, displacing AChE and releasing CR. This has been previously shown to be 
tracked visually but more importantly could be quantified by UV-Vis. This allowed for the 
direct determination of CR release kinetics based on the rate of phosphorylation of AChE 
by each of the different surrogate organophosphates tested.  
 The design of the detection system to differentiate between organophosphates by 
releasing CR consistent with the rate of phosphorylation is highly advantageous. The 
ability for a detection system to quickly and easily discern the threat level of an exposed 
area is crucial to limiting exposure. With the current enzyme-inhibitor trigger system using 
the specific enzyme that becomes inhibited when exposed to a nerve agent, allows for the 
response of the system to be directly proportional and limits false positives. This has shown 
promise within triggered-release systems in which the specificity of the trigger can be 














1. Climent, E.; Marti, A.; Royo, S.; Martinez-Manez, R.; Marcos, M. D.; Sancenon, 
F.; Soto, J.; Costero, A. M.; Gil, S.; Parra, M. Chromogenic detection of nerve 
agent mimics by mass transport control at the surface of bifunctionalized silica 
nanoparticles. Angew. Chem. Int. Ed. Engl. 2010, 49, 5945-5948. 
2. Royo, S.; Martinez-Manez, R.; Sancenon, F.; Costero, A. M.; Parra, M.; Gil, S. 
Chromogenic and fluorogenic reagents for chemical warfare nerve agents' 
detection. Chem. Commun. 2007, 4839-4847. 
3. Lee, J.; Seo, S.; Kim, J. Colorimetric detection of warfare gases by 
polydiacetylenes toward equipment-free detection. Adv. Funct. Mater. 2012, 22, 
1632-1638. 
4. Nieuwenhuizen, M. S.; Harteveld, J. L. N. Studies on a surface acoustic wave 
(saw) dosimeter sensor for organophosphorous nerve agents. Sens. Actuators B 
1997, 40, 167-173. 
5. Ngeh-Ngwainbi, J.; Foley, P. H.; Kaun, S. S.; Guilbault, G. G. Parathion 
antibodies on piezoelectric crystals. J. Am. Chem. Soc. 1986, 108, 5444-5447. 
6. Yang, Y. M.; Ji, H.-F.; Thundat, T. Nerve agents detection using a cu2+/l-cysteine 
bilayer-coated microcantilever. J. Am. Chem. Soc. 2003, 125, 1124-1125. 
7. Hartmann-Thompson, C.; Hin, J.; Kaganove, S. N.; Keinath, S. E.; Keeley, D. L.; 
Dvornic, P. R. Hydrogen-bond acidic hyperbranched polymers for surface 
acoustic wave (saw) sensors. Chem. Mater. 2004, 16, 5357-5364. 
8. Yuehe, L.; Fang, L.; Joseph, W. Disposable carbon nanotube modified screen-
printed biosensor for amperometric detection of organophosphorus pesticides and 
nerve agents. Electroanalysis 2004, 16, 145-149. 
9. Zhou, Y.; Yu, B.; Shiu, E.; Levon, K. Potentiometric sensing of chemical warfare 
agents: Surface imprinted polymer integrated with an indium tin oxide electrode. 
Anal. Chem. 2004, 76, 2689-2693. 
 134 
10. Yu, D.; Volponi, J.; Chhabra, S.; Brinker, C. J.; Mulchandani, A.; Singh, A. K. 
Aqueous sol-gel encapsulation of genetically engineered moraxella spp. Cells for 
the detection of organophosphates. Biosens. Bioelectron. 2005, 20, 1433-1437. 
11. Anitha, K.; Mohan, S. V.; Reddy, S. J. Development of acetylcholinesterase silica 
sol-gel immobilized biosensor - an application towards oxydemeton methyl 
detection. Biosens. Bioelectron. 2004, 20, 848-856. 
12. Simonian, A. L.; Grimsley, J. K.; Flounders, A. W.; Schoeniger, J. S.; Cheng, T. 
C.; DeFrank, J. J.; Wild, J. R. Enzyme-based biosensor for the direct detection of 
fluorine-containing organophosphates. Anal. Chem. Acta 2001, 442, 15-23. 
13. Wang, J. Microchip devices for detecting terrorist weapons. Anal. Chem. Acta 
2004, 507, 3-10. 
14. Steiner, W. E.; Klopsch, S. J.; English, W. A.; Clowers, B. H.; Hill, H. H. 
Detection of a chemical warfare agent simulant in various aerosol matrixes by ion 
mobility time-of-flight mass spectrometry. Anal. Chem. 2005, 77, 4792-4799. 
15. Miao, Y.; He, N.; Zhu, J. J. History and new developments of assays for 
cholinesterase activity and inhibition. Chem. Rev. 2010, 110, 5216-5234. 
16. Mulchandani, P.; Chen, W.; Mulchandani, A. Microbial biosensor for direct 
determination of nitrophenyl-substituted organophosphate nerve agents using 
genetically engineered moraxella sp. Anal Chim Acta 2006, 568, 217-221. 
17. Wang, M.; Gu, X.; Zhang, G.; Zhang, D.; Zhu, D. Continuous colorimetric assay 
for acetylcholinesterase and inhibitor screening with gold nanoparticles. 
Langmuir 2009, 25, 2504-2507. 
18. Van Dyk, J. S.; Pletschke, B. Review on the use of enzymes for the detection of 
organochlorine, organophosphate and carbamate pesticides in the environment. 
Chemosphere 2011, 82, 291-307. 
  
 135 
19. Hossain, S. M.; Luckham, R. E.; Smith, A. M.; Lebert, J. M.; Davies, L. M.; 
Pelton, R. H.; Filipe, C. D.; Brennan, J. D. Development of a bioactive paper 
sensor for detection of neurotoxins using piezoelectric inkjet printing of sol-gel-
derived bioinks. Anal. Chem. 2009, 81, 5474-5483. 
20. Simonian, A. L.; Good, T. A.; Wang, S. S.; Wild, J. R. Nanoparticle-based optical 
biosensors for the direct detection of organophosphate chemical warfare agents 
and pesticides. Anal. Chim. Acta. 2005, 534, 69-77. 
21. Landry, C. C.; Nassivera, T. W. US Patent Appl. 20090220791. 
22. Gallis, K. W.; Landry, C. C. US Patent 2002, 6334988. 
23. Smith, P. K.; Krohn, R. I.; Hermanson, G. T.; Mallia, A. K. Measurement of 
protein using bicinchoninic acid. Analytical … 1985. 
24. Pickering, W. R.; Malone, J. C. The acute toxicity of dichloroalkyl aryl 
phosphates in relation to chemical structure. Biochemical pharmacology 1967. 
25. Chemical listing and documentation of revised idlh values 
http://www.cdc.gov/niosh/idlh/intridl4.html (accessed April 4, 2016). 
26. Kim, K.; Tsay, O. G.; Atwood, D. A.; Churchill, D. G. Destruction and detection 
of chemical warfare agents. Chem. Rev. 2011, 111, 5345-5403. 
27. Fukuto, T. R. Mechanism of action of organophosphorus and carbamate 
insecticides. Environ. Health Perspect. 1990, 87, 245-254. 
28. Villatte, F.; Marcel, V.; Estrada-Mondaca, S.; Fournier, D. Engineering sensitive 
acetylcholinesterase for detection of organophosphate and carbamate insecticides. 
Biosens. Bioelectron. 1998, 13, 157-164. 
29. Lewis, V. E.; Donarski, W. J.; Wild, J. R.; Raushel, F. M. Mechanism and 
stereochemical course at phosphorus of the reaction catalyzed by a bacterial 
phosphotriesterase. Biochemistry 1988, 27, 1591-1597. 
 136 
30. Ellman, G. L.; Courtney, K. D.; Andres, V., Jr.; Feather-Stone, R. M. A new and 
rapid colorimetric determination of acetylcholinesterase activity. Biochem. 
Pharmacol. 1961, 7, 88-95. 
31. Eyer, P.; Worek, F.; Kiderlen, D.; Sinko, G.; Stuglin, A.; Simeon-Rudolf, V.; 
Reiner, E. Molar absorption coefficients for the reduced ellman reagent: 
Reassessment. Anal. Biochem. 2003, 312, 224-227. 













CHAPTER 5: CONCLUSION 
 
The goal of this study was to develop a molecular recognition system for 
organophosphate detection to eliminate the problem with false positives seen with previous 
detection systems. To do this, the use of a MSN as the scaffold to contain the optical signal, 
the dye Congo Red, is capped with an enzyme to block the pores to retain the loaded dye. 
The mode of attachment of the enzyme (OPH or AChE) was through the use of a 
competitive inhibitor of the enzyme. Testing of the triggered-release mechanism with 
either substrate or organophosphates was thoroughly explored to test the stability of the 
tethering, and relate the dye release kinetics to the rate of AChE inhibition. 
In the first molecular recognition system utilized OPH for a dual detection and 
decontamination system. The enzyme was tethered to the surface of the particle with the 
competitive inhibitor DEABP. The competitive inhibition of OPH, both free in solution 
and immobilized DEABP, was confirmed through enzyme kinetics testing using 31P NMR. 
The competitive inhibition was used as the trigger for the release of OPH, uncapping the 
pores and releasing of CR. Color change of the particles was used as visual indication, 
along with quantification by UV-Vis. This system worked with not only the ideal 
conditions, but within cell culture media containing a variety proteins and growth factors, 
 maintain the activity of OPH and detection of CR. While OPH had a fast rate of hydrolysis, 
this hindered probing the release system further. As more paraoxon was added, free OPH 
would hydrolyze the organophosphate faster than the OPH could be displaced from the 
surface of APMS. The use of a sacrificial enzyme that would become inactive after its  
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release would allow for further testing to be completed.  
The selection of a sacrificial enzyme relied on an enzyme that would become 
inactive after the addition of an organophosphate. Organophosphorus compounds target 
AChE and inhibit the hydrolysis of ACh through inhibition of the AChE active site. This 
would allow the use of AChE as a sacrificial enzyme that would release from the surface 
of the particle, allowing CR to escape. For this system, the competitive inhibitor tacrine 
was used to temporarily tether AChE to the surface of APMS. Confirmation of the 
competitive inhibition was performed using the Ellman’s method to confirm the 
competitive inhibition of tacrine. This would ensure that the enzyme was tethered through 
its active site and would be displaced by the introduction of an organophosphate. Similar 
testing to the OPH-based system, the visual color change of the particles was confirmed 
and quantified by UV-Vis. Testing the system against false positives was conducted with 
both the AChE substrate, AtCh, and paraoxon. This included phosphate buffer, FBS and 
human serum, which CR released only after the introduction of AtCh or paraoxon. This 
showed the benefit of having a molecular recognition system that only released in when 
exposed to an organophosphate, despite having a large concentration of proteins in 
solution. 
The final exploration of the AChE-based detection system was testing against 
different organophosphates. The nerve agent surrogates used were paraoxon, parathion, 
demeton-s, and malathion, ranked from the highest rate of inhibition to the lowest. Changes 
in the rate of AChE inhibition could be tracked with changes in the rate and amount of CR 
released. The decrease in inhibition rate resulted in a slower release of AChE from the  
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surface of APMS due to the disruption of the inhibitor-enzyme tether. The slower AChE 
was released, the smaller amount of CR released from the material. The sensitivity of the 
system to different inhibition rates represents the use of this system for the detection of a 
variety of organophosphates, with an increased signal for faster inhibiting 
organophosphates. 
The use of an enzyme-inhibitor molecular recognition system shows promise in 
the area of organophosphate detection by eliminating the problem with false positives and 
giving a visual detection. The visual detection broadens the scope of use among untrained 
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